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I. INTRODUCTION 
A. Statement of Problem 
Increased nasal discharge and coughing have been associated with the 
use of expectorants. Several drugs. may produce such effects, either by 
opening the air passages or ·augmenting the secretion of normal respiratory 
fluid. A list of such expectorants in.eludes ethylenediamine dihydriodide -
(EDDI), potassium iodide,.potassium and ammonium chloride, guaiacol, oil of 
eucalyptus, creosote, carbon dioxide, and sulfathiazole (Jones, 1965). It 
is generally considered that these expectorants have a beneficial effect by 
aiding the clearing of tenacious exudate from the upper respiratory tract. 
Iodine compounds have been used as expectorants, increasing the output 
of respiratory exudates in animals suffering from mild chronic or subacute 
respiratory diseases. Oral administration of organic iodine compounds such 
as EDDI has been preferred to inorganic iodides because of the less irri-
tant effect of the organic compounds on the gastric mucosa. 
Recently certain beef producers and veterinarians have suspected that 
. EDDI has adverse effects on calves suffering from respiratory disease. 
They have postulated that EDDI as an expectorant causes inflammation of the 
respiratory tract and consequently makes exposed animals more susceptible 
to microbial invasion (McCauley and Johnson, 1972; McCauley~ al., 1971, 
1972). 
EDDI is recommended for treatment of foot rot, lumpy jaw, and mild 
respiratory diseases in cattle at a dosage of 400-500 mg/head/day for 2-3 
weeks. Feeding EDDI at a continuous level of 50 mg/head/day is recommended 
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as a preventative for foot rot and lumpy jaw (Herrick, 1972; Miller Pub-
lishing Company, 1975). 
Livestockmen have suspected similar detrimental effects from feeding 
urea due .to the release of ammonia upon hydrolysis. Urea is commonly used 
as a substitute for natural proteins. A level 9f 0.1 lb urea/head/day is 
recommended for a 500-lb calf (Lloyd, 1970). In addition, it has been pos-
tulated that increased release of ammonia due to urea hydrolysis may 
increase EDDI breakdown and consequently result in a release of ethylene-
diamine, a proven bronchodilatator (Lulling~~., 1958; Noel, 1969). 
Recent studies by Brown (1973) make it possible to experimentally 
reproduce a respiratory disease complex in susceptible cattle by interac-
tion of Haemophilus somnus, infectious bovine rhinotracheitis (!BR) virus, 
and bovine virus diarrhea (BVD) virus. In addition,. foot rot has been 
experimentally reproduced in cattle by interaction of Spherophorus 
necrophorus and Bacteriodes melaninogenicus (Berg, 1972). 1 
B. Objectives 
The objectives of this experiment were to: (1) determine the effects 
of high EDDI exposure (500 mg/head/day) upon experimentally induced bovine 
respiratory disease complex as manifested by weight gains, body tempera-
ture, and clinical signs, (2) determine the effects of low EDDI exposure to 
calves (50 mg/head/day), alone or combined with 0.1 lb urea/head/day, on 
susceptibility to, and severity of, the respiratory disease complex and 
foot rot agents, (3) monitor those parameters (packed cell volume,. white 
1
Berg, John, 1972, Personal conmiunication, University of Missouri, 
Department of Veterinary Microbiology, Columbia, Missouri. 
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blood cell count, plasma proteins, fibrinogen, blood urea nitrogen, serum 
glutamic oxaloacetic transaminase, and white blood cell differentials) that 
reflect hematic cellular changes and certain serum enzyme activities, 
(4) study blood ammonia and total blood iodine levels, indicative of urea 
and EDDI absorption and metabolism, and (5) perform viral and bacterial. 
isolations plus antibody determinations to assess infectivity and immunity 
to induced infectious diseases, 
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II. LITERATURE REVIEW 
A. Iodides and Respiratory Tract Fluid 
1. Mechanism 
The expectorant action of iodides has been studied by Boyd ~ al. 
(1945) using potassium iodide at a dosage of 0.1-5.0 g/kg in cats. These 
animals with severed anterior and posterior branches of the vagus nerve had 
no·increased output of the respiratory tract fluid (RTF) as compared to 
intact animals, which experienced increased nasal discharge at a maximum 
degree 2 hours later. This. study. indicated that the expectorant action of 
iodides in the cat was by way of vagal reflex from the stomach. Two 
organic iodide compounds, Siomine (hexamethylenetetramine tetraiodide, 
79 percent iodine) and Iod-ethamine · (ethylenediamine dihydriodide, 80 per-
cent iodine) at 20 mg/kg increased output of the RTF; but no other organic 
compounds, such as iodized proteins, fatty acids, or oils, had this effect. 
Boyd and Blanchaer (1945) reported that the reputed mucus-liquifying 
effect of iodides in rabbits and cats was due to a simple increase. in out-
put of normal RTF, which had a low viscosity and a pH near the neutral 
point. This could account for the therapeutic effect of iodides on mild 
respiratory diseases associated with thick mucus, coughing and reduced flow 
in the air passages. These workers also suggested that the appearance of 
iodine-containing compounds in the RTF are of a nature suggesting simple 
diffusion from the blood. 
Organic iodides such as EDDI have been used in cattle as expectorants 
in the treatment of mild respiratory infections and as nutritional iodide 
sources (Miller Publishing Company, 1975). In recent field observations, 
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McCauley and Johnson (1972) suggested that caution should be taken in the 
use of iodides for the treatment of respiratory diseases. A similar cau-
tion is also given on labels of feeds containing EDDI for aid in the treat-· 
ment of mild respiratory diseases, foot .rot, and lumpy jaw: "do not admin-
ister to animals showing symptoms of acute respiratory conditions; treat 
animals with caution until tolerance is determined because of variation in 
susceptibility to iodides" (Miller Publishing Company, 1975). 
B. Effects of Iodides on the Inflammatory Process 
Kolmer il al. (1916) found a marked positive Luetin reaction 
(Noguchi 's syphilis reaction) among a group of healthy, nonsyphilitic per-
sons who were simultaneously receiving potassium iodide (KI). This reac-
tion caused inflammatory phenomena to develop and progress to pustulation 
.at the site of a former Luetin reaction. Sherrick (1915) has observed sim-
ilar effects among guinea pigs following administration of KI. A positive 
pustular or nodular Luetin reaction was obtained in 99 percent of all 
cases, irrespective of the presence of syphilis. 
Woody (1951), in attempts to treat chronic inflammatory processes in 
animals, found that the combined effects of KI and streptomycin caused 
enhancement of the. inflammatory conditions. Marchese il tl• (1952) found 
similar effects from iodized oil used in treating pulmonary tuberculosis. 
Sutter il tl· (1958) demonstrated that cuprous iodide (Cul) fed at 
250 mg/kg/day succeeded in causing a reduction of granuloma pouch inflamma-
tion in guinea pigs. However, Stone and Carolyn (1967) reported that 
33 mg KI/head/day enhanced rather than reduced a dermal inflammatory proc-
ess in guinea pigs. Oral administration of KI significantly enhanced the 
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diameter of dermal inflammations. In Stone and Carolyn's experiment, 
results were evaluated after 24, 48, and 72 hours. After local injection 
of collagenase, results were positive at 24 and 48 hours but not at 72 
hours. Stone and Carolyn (1967) also made topical applications of KI on 
skin of human volunteers and found that lesions of those treated ·were 
greater than those of the controls. Two volunteers in this study noted 
flare-ups of pain in the joints in which they had previously had discom-
fort. It was concluded that iodides enhance rather than inhibit certain 
types of dermal inflammations. 
Mielenz and Rozitis (1968) initiated an investigation to determine 
whether or not orally administered iodides would have anti-inflammatory 
properties. Five types of experimental chronic inflammations were induced: 
granuloma pouch, cotton granuloma, corrogenan croton oil edema, turpentine-
induced edema, and abscess. Administration of KI resulted in inhibition of 
granuloma pouch but no inhibition of the other types of inflammation. 
These data are suggestive of a specific anti-fibrotic effect of KI and cor-
roborate the findings of Sutter il al. (1958). 
C. Iodine Toxicity 
Iodine administered as KI or EDDI has been reported to produce toxi-
cosis in sheep at dosages ranging from 0.15 to 0.62 g iodine/head/day for 
3 weeks (McCauley il .!!!,., 1971). Treated animals had higher body tempera-
ture, appeared sluggish, and consumed less feed than controls, particularly 
at high iodine intake. Weight gains for sheep on zero and 0.15 g iodine/ 
head/day levels were similar. Iodine from a KI source at 0.62 g/head/day 
was associated with reduced weight gains to a greater extent than iodine 
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from EDDI sources. At 7 days, serum protein bound iodine levels were 6.3 
to 7. 9 µg/100 ml for controls and 5 .4 to 45 µg/100 ml for lambs receiving 
iodine. No gross lesions were observed at necropsy of treated animals. 
Buck (1970) reported the following signs in 500-600 lb calves fed 
2-24 g EDDI/head/day. Seromucoid nasal discharges occurred intermittently 
.throughout the experiment once the exposure to EDDI had started. In addi-
tion, an occasional cough; scaliness of the skin of the dorsum, neck, ears, 
brisket, shoulders, and head of the tail; and slight sloughing of the epi-
dermis were noted. These changes appeared more pronounced at 8 g EDDI/ 
head/day and were very evident at 20 g/head/day and over. The signs dis-
appeared 2 weeks after EDDI exposure was suspended. No temperature varia-
tion, hematologic alterations, nor changes in cholinesterase activity were 
observed. In this experiment, the calves refused to eat the high iodine-
containing feed, as opposed to McCauley~ &·'s field findings (1972) 
where animals were eating vigorously. It is imp.ortant to note, however, 
that in McCauley's findings 50 mg EDDI/head/day was given, whereas EDDI 
levels varied from 2 g EDDI/head/day up to 20 g/head/day in Buck's experi-
ment. At this point, it is important to clarify that coughing and 
increased nasal discharge are iodine expectorant effects. They are con-
sidered by some writers, however, to be signs of iodine toxicosis. In 
cases of true iodine toxicosis, coughing and increased nasal discharge are 
continuous and more severe, and erythema of the skin is also observed 
(Garner~ ll•• 1967; Buck, 1970)·. Vomiting, loss of appetite, central 
, 
nervous and cardiac depression, muscular spasms, and drowsiness are also 
reported·in acute iodine toxicity. 
8 
Decreased weight gains in calves receiving high dietary iodine has 
been postulated to be due to increased thyroid activity or failure of iron 
absorption from the intestinal tract. This is reportedly due to decreased 
gastric pH and degeneration of the gastric parietal cells (Newton~ .!U,., 
1974). 
D. Urea Toxicity 
Urea has been ·blamed as a detrimental factor in some bovine respira-
tory diseases. The toxicity of urea formulations is dependent upon their 
hydrolysis to ammonia. Cattle and other ruminants are more susceptible 
than monogastric animals due to their high ruman urease content. Toxicosis 
from nonprotein nitrogen compounds results from the absorption of ammonia 
from the gastrointestinal tract into the blood stream. An alkaline rumen 
pH enhances urea hydrolysis (Lloyd, 1970). 
Although alkalosis of the rumen occurs during urea toxicosis, a meta-
bolic acidosis develops. This may indicate an inhibition of the citrate 
cycle. A concomitant decrease in blood pH and urine excretion appears. 
Death is probably. due to a hyperkalemic cardiac blockage and cessation of 
respiration (Lloyd, 1970). 
The possibility of ammonia being aspirated at the moment of eructation 
has been theorized. Thus, aspiration of eructated ammonia could cause 
irritation and increased susceptibility to respiratory infectious agents. 
Such a theory is not plausible; however, because ammonia is bound in liquid 
form, ammonium hydroxide, and unless the rumen pH is elevated to 8-9, gas• 
eous ammonia would not be available for eructation (Lloyd, 1970). 
Doses of 1.0-1.5 g urea/kg are considered to be lethal in ruminants, 
but 0.3-0.5 g urea/kg may also be toxic. Factors such as fasting, age of 
9 
the animal, high roughage diets, lack of conditioning to high urea diets, 
and high ruminal pH may augment toxic effects of urea (Buck tl al., 1973). 
In urea toxicosis, areas of congestion in the lungs and brain have 
been reported. Extravascular erythrocytes, suggestive of antemortem hemor-
rhages, were also mentioned. Renal congestion, swelling, and an amorphous 
hyaline substance localized in the glomerulli have been described (Clark 
tl al., 1951). 
E. Infectious Bovine Rhinotracheitis 
Mcintyre ·(1954) first experimentally reproduced an upper respiratory 
infection in cattle by injecting defibrinated blood from typical field 
cases by either subcutaneous or conjunctival sac .route. Postmortem changes 
were described as congestion and mucopurulent exudate in the upper respira-
tory tract. 
Isolation and identification of infectious bovine rhinotracheitis 
(!BR) virus in tissue cultures were carried out by Gillespie tl al. (1957). 
Experimental transmission by intratracheal inoculation of tissue culture 
fluid induced temperature elevation, lacrimation, inappetence, and depres-
sion. In calves inoculated intranasally, the virus concentration was 
greater in nasal exudate, but calves inoculated intratracheally showed a 
high concentration initially in the lungs and later in nasal mucosa. They 
also found a high concentration of virus in nasal discharge 5 days post-
inoculation. 
Clinical signs and virus identification were also described by 
McKercher and Straub (1960). These consisted of ocular discharges, redness 
and congestion of the muzzle (red nose), stiff joints, weight loss, and 
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diarrhea, In addition, Kendrick and Straub (1967) reported respiratory 
lesions, fetal infection, and death i!!, ~several days before abortion 
occurred. Characteristic focal necrosis of the liver and renal cortex were 
also reported: 
Antibody formation has been described by McKercher and Straub (1960). 
A group of calves inoculated with !BR virus showed a rapid rise in antibody 
titers after 12 days, although t·here were some variations. Some titers 
fluctuated widely, while others remained fairly constant. In some animals 
the titers still were rising 10 months after initial exposure to the virus. 
It has been shown that !BR virus produces different syndromes, such as con-
junctivitis, abortion, balanopostitis, fatal calfhood disease, encephalitis, 
infectious postular vulvovaginitis, infertility, mastitis, and endometritis 
(House, 1972). 
F. Haemophilus somnus Infection in Feedlot Cattle 
Thromboembolic meningoencephalitis (TEME) was first reported in the 
United States in 1956 by Griner £..!:. al. This disease was described as an 
acute or chronic infectious embolic meningoencephalitis, a secondary dis-
ease of cattle. It was described as a random dissemination of infected 
emboli in the blood vessels of the brain and meninges. The first report 
was based on postmortem examination of cattle that had died of clinically 
diagnosed infectious TEME. Macroscopic and microscopic changes indicated 
multiple necrotic foci in the brain and meninges, infiltrated with inflam-
matory cells. Thrombosed blood vessels of the brain frequently contained 
fibrin and bacteria. 
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Kennedy .!!!. !!!.· (1960) further characterized the pathologic changes in 
this disease. They succeeded in produc\ng these changes by infe.cting 
calves with a Haemophilis-like organism. A gram negative Haemophilis-like 
organism was isolated from cattle suffering from an epizootic bacterial 
encephalitis. The characteristic pathologic changes were described micro-
scopically as a bacterial vasculitis of the brain leading to thrombo'sis and 
infarction. 
Panciera et al. (1968) described an experimental reproduction of a --
septicemic state caused by a Haemophilis-like organism. Clinical signs 
were described in 3 syndromes: those of the central nervous system, respi-
ratory tract, and joints. The first syndrome was characterized by fibrino-
purulent meningitis with hemorrhagic necrotic foci, localized in the brain 
near the cortical gray matte~. The second syndrome involved the respira-
tory tract, primarily lamina prqpria and submucosa of the larynx. Changes 
in the synovial membrane were involved in the third syndrome, consisting of 
congestion, edema, and fibrinopurulent exudate which progressed to a 
chronic state and manifested villous proliferation and stratification of 
synovial cells.. The Haemophilus-like organism was best isolated by yolk 
sac inoculation of 6- to 8-day-old chicken embryos. The septicemic state 
was also reproduced in a cow by intravenous inoculation of the Haemophilus-
like organism suspension; lesions produced were similar to those of the 
field cases. 
Bailie (1969) described morphologic and biochemical characteristics of 
the TEME agents. Bailie also gave the new term of Haemophilus somnus to 
this TEME agent. The lesions that commonly had been ascribed to this con-
dition refer to the central nervous system, respiratory tract, and joints; 
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however, Brown .!l.J:. .!!!.· (1970a) have referred to skeletal muscle lesions that 
may superficially resemble those of black leg. These lesions appear to be 
a cons~quence of endothelial damage to blood vessels. Lesions of kidney 
and gastrointestinal tract suggestive of Clostridium perfringes entero-
toxemia were also observed. 
Dillman (1969) gave the name of polypoid tracheitis to the tracheal 
lesion consistently observed in chronically coughing feedlot cattle. It is 
suspected that this lesion is due to a chronic bacterial infection, often 
following the more acute g. somnus infections. 
Brown .!l.J:..!!l· (1970b) described the epidemiology, gross and microscopic 
tissue changes, and serologic and differential diagnostic procedures of 
g. somnus infections. They considered g. somnus to be a primary pathogen 
in the shipping fever syndrome. Intranasal inoculation of susceptible cat-
tle with g. somnus resulted in pneumonia and septicemia not unlike shipping 
fever. 
G. Bovine Virus Diarrhea 
As early as 1946, Olafson .!l.J:. al. described an acute contagious and 
transmissible disease of cattle characterized by leukopenia, high tempera-
ture, salivation, nasal discharges, depression, anorexia, dehydration, and 
subsequent abortion. Lesions consisted of ulcers and necrosis of the 
mucous membrane of the lips, cheeks, tongue, pharnyx, and esophagus 
(Olafson and Richard, 1947). Pritchard .!l.J:. al. (1956) reported a transmis-
sible disease of cattle in Indiana which had many features similar to those 
described by Olafson in New York. Ramsey and Chivers (1953) described a 
more severe condition in Iowa, differing in some clinical features. The 
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3 bovine diseases from New York, Indiana, and Iowa possessed fundamentally 
similar lesions, and the virus isolated from each area was identical. In 
addition to the previous characterizations, Ramsey and Chivers (1953) 
described coughing, salivation, conjunctivitis, oral erosions, and necrotic 
lesions in the upper alimentary tract, such as hemorrhagic abomasitis, 
Inflammation of the lower dige~tive tract as well as deep necrosis of the 
Peyer's patches were also reported. Dermatitis and scab formation at the 
junction of the skin and hoof, at the base of the horn, and occasionally on 
the perineum were seen. 
Gillespie il &· (1960) made a major finding in identification of BVD 
virus when they isolated a cytopathogenic virus from the spleen of a calf 
that had died of BVD in Oregon. The clinical signs fit very well with 
those described above. Findings of a cytopathogenic strain offered possi-
bilities for measurements of virus and antibodies. This strain also has 
become the prototype virus used in many diagnostic laboratories. 
After the cytopathogenic virus isolation of BVD disease and the demon-
stration that serum from recovered cattle neutralized the virus, a diagnos-
tic test was developed. Malmquist (1968) studied the relationship between 
immunity and neutralizing antibodies. It was determined that the serum 
neutralization test is at least 95 percent accurate and hence usable as a 
substitute for a direct challenge. 
Attempts to demonstrate BVD pathogenesis failed when Malmquist (1968) 
used a BVD virus isolated and adapted to tissue culture. Several calves 
artificially inoculated with the BVD virus had a persistent viremia and 
failed to develop neutralizing antibodies for up to 4 months, the longest 
period attempted. These animals also failed to produce complement-fixing 
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antibodies. This failure to respond immunologically is often attributed to 
immunologic tolerance. In this case, previous intrauterine exposure was 
the suspected cause of the failure. Lymphoid depletion is a consistent 
clinical finding in this disease. Animals suffering lymphocyte depletion 
are immunologically incompetent, and consequently the defense mechanism of 
the host ·is adversely affected. The suppression of interferon formation by 
BVD virus is considered to be responsible for exalting the action of a more 
benign virus. By far the most common form of BVD virus infection in older 
animals is the subclinical form; it probably accounts for the high inci-
dence of animals with high serum titers. 
Passive immunity duration on the average is approximately 30 weeks 
after birth. Whenever this parental immunity ends, a higher incidence of 
BVD disease is reported. This usually occurs in calves from 6 to 14 months 
old. Active immunity develops following artificial exposure, since comple-
ment fixation antibodies and virus neutralizing antibodies are produced 
first and reach a peak about 5 to 6 weeks postinfection. 
H. Shipping Fever 
Several attempts to reproduce the shipping fever syndrome have failed; 
however, one of the most common microorganisms isolated from affected ani-
mals has been Pasteurella .!U!.E.· (Gale and King, 1961; Hamdy ~al., 1963). 
A pure culture of Pasteurella .!U!.E.· failed to reproduce this syndrome. It 
was suggested that this genus was not the primary cause. Hamdy ~ al. iso-
lated a virus using nasal washings of animals suffering from shipping fever; 
a mild disease was induced in calves exposed to this virus. The most severe 
symptoms and lesions were found in calves that were simultaneously exposed 
15 
to E_. multocida, E_. hemolytica, Myxovirus parainfluenza, and physical 
stress. 
Observations at the Veterinary Diagnostic Laboratory, Iowa State Uni-
versity, have found that susceptible calves naturally exposed to BVD car-
riers and/or vacinnated against BVD died 2 weeks later due to !!· somnus 
infection. This substantiated a close relationship between BVD and 
!!· somnus (Brown, 1973). Calves are usually stressed due to shipment or 
severe climatic changes. Unfortunately, this stress may coincide with 
exposure to a respiratory infection due to !BR virus or !!· somnus. Lympho-
cytic depletion and interferon suppression due to BVD infection plus stress 
may enhance the susceptibility to Ji. somnus and !BR virus to an extent that 
carriers are converted to clinica'lly sick animals. 
I. Foot Rot 
Gupta il al. (1964) defined foot rot as an infectious disease of the 
feet of cattle, characterized by erosions, foul-smelling sores, and deep 
dermatitis. Foot rot is localized either between the claw or in soft tis-
sue of the feet; it usually starts at the heels and spreads under the 
hooves or through the upper foot, where it may involve the joints and deep 
structures of the foot. 
Clinically, foot rot is first evidenced by swelling and slight lame~ 
ness which becomes marked as the infection progresses. Several predispos-
ing factors have been established: (1) wet feces and mud that may soften 
and macerate the interdigital epidermis, (2) dried and frozen mud and 
stones that may bruise the tissue and lower its resistance, (3) anaerobiosis 
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created by mud, feces, and straw layers, and (4) other conditions involving 
any sore in the foot. 
Several experimental designs have been employed in at attempt to iso-
late the true foot rot agent. Moore (1898) has shown that the injection of 
pure Spherophorus necrophorus was not successful in repro~ucing the dis-
ease. Gupta~ al. (1964) utilized pure bacterial cultures isolated from 
lesions of the infections, but he also was unsuccessful in reproducing foot 
rot. A mixture of a gram-negative Fusiform-like bacteria and Staphylococci 
was associated with a lesion that resembled foot rot. Staphylococci alone 
did not produce this condition. 
Egerton and Parsonson (1969) ascertained that Fusiformis nodosus and 
§.. necrophorus were the organisms that penetrated into normal epidermal 
tissue and referred to other bacteria as secondary invaders. It was also 
reported that mild lesions produced by !· nodosus were aggravated by 
§.. necrophorus. Thus, it was cone luded that foot rot is caused by 
!· nodosus (a transmitting agent) in conjunction with §.. necrophorus and 
possibly actively influenced by other microorganisms. 
Egerton ~ al. (1969) examined several hundred smears from· foot rot in 
cattle and sealed foot rot in sheep, showing the similarity of the 2 condi-
tions. On smears stained using the method of May-Greenwald Giemsa, it was 
found that!· nodosus, Spirochaetes, and 5 species of Fusiformis bacteria 
were prevalent; §.. necrophorus was not discerned at all. 
Wright ~ al. (1972) emphasized the need of a lacerating factor for 
experimental foot rot induction in pigs. In their experiment, a rough con-
crete floor surface was shown as a decisive factor in the foot rot induc-
t:t.on. 
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There is an established connection between respiratory disease in cat-
tle caused by !!· somnus and subsequent occurrence of epidemic foot rot. 
Epidemic foot rot is a misnomer for suppurative ·polyarthritis. 
In our experimeqt, we are dealing with true foot rot as opposed to 
polyarthritis, which is produced by injecting a combined suspension of 
.[. necrophorus and Bacteriodies melaninogenicus. 2 True foot rot has been 
clinically identified by lameness, swelling of the lower end of the leg, 
and interdigital necrotic pododermatitis. The right combination of the 
2 bacteria mentioned above plus the initial injury or penetration of the 
skin are apparently necessary to develop true foot rot. 
2serg, John, 1972, Personal communication, University of Missouri, 
Department of Veterinary Microbiology, ·columbia, Missouri. 
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III. MATERIALS AND METHODS 
A. Animals 
Forty heifers of crossed Shorthorn, Hereford, and Angus breeds 3 were 
used. These heifers were approximately 9 months old with a mean weight of 
423.1 pounds. They were randomly arranged in 5 groups of 8 each. An ear 
tag with a number was used for identification. The experiment was con-
tinued from February 20 to April 28. These 10 weeks were divided into 3 
periods: Period 1 consisted of a 2-week acclimatization period; Period 2 
consisted of the following 3 weeks; and Period 3 included the remaining 
5 weeks. 
B. Facilities 
The cattle were housed in a shed open to the south. A wooden fence-
line bunk for feeding the concentrate was installed in each pen. Water was 
provided by automatic electrically heated waterers. In order to periodi-
cally record weights, a scale was placed in the runway leading to the han-
dling chute. 
C. Feed and Care 
1. Basal ration 
The basal ration consisted of the concentrate, hay, and salt ~ libi-
.!:£!!!· The concentrate consisted of 73 percent ground corn, 18 percent pro-
tein supplement (90 percent soybean oil meal and 10 percent wheat mid-
dlings), and 9 percent of a vitamin and mineral mixture (vitamins A and E, 
3
on loan from Walnut Grove Products, Atlantic, Iowa. 
19 
calcium, phosphorus, and 90 percent soybean oil meal as vehicle). 4 The 
concentrate was fed twice a day at a rate of 6 lb/head/day. 
2. Chemical additives 
The feeding program was as follows (Table 1): The 5 groups of animals 
were fed the basal ration during the 2-week acclimatization period (Period 
1). During infectious challenge (Periods 2 and 3), the feeding program was 
as outlined below: 
Group 1 Thirty percent of the total protein supplement of the 
basal ration was replaced by 0.1 lb urea/head/day. 
Group .f. The basal ration plus ethylenediamine dihydriodide (EDDI) 
as a feed additive were given. Five hundred mg EDDI/head/day was fed dur-
ing Period 2 (21 days), followed by 50 mg EDDI/head/day during Period 3, 
until the experiment was completed 35 days later. 
Group l Thirty percent of the protein supplement of the basal 
ration was replaced by 0.1 lb urea/head/day plus 50 mg EDDI/head/day. 
Groups i and .2. The basal ration with no additives was fed. 
D. Challenge Studies 
Two serum samples were taken during Period 1 before challenge of 
infectious agents in order to determine the immune status of each animal. 
After acclimatization and at the beginning of Period 2, BVD vaccine5 was 
given to 4 animals in each of Groups 1, 2, 3, and 4 that had no BVD anti-
4
Topper 10 Plain,®Walnut Grove Products, Atlantic, Iowa. 
5
Jensine® BVD vaccine, modified live virus, Jensen-Salsbery Labora-
tories, Kansas City, Kansas. 
Table 1. Schedule for administration of EDDI, urea, and infectious agents to cattle 
Week 
1 
2 
Group 1 
Urea 
0.1 lb/hd/dy 
8 weeks 
Group 2 
EDDI 
500 mg/hd/dy 
3 weeks; 
50 mg/hd/dy 
5 weeks 
Chemicals in feed 
Group 3 
EDDI-Urea 
50 mg EDDI/hd/dy-
0.1 lb urea/hd/dy 
8 weeks 
Period 1 (2 weeks) 
Acclimatization period 
Period 2 (3 weeks) 
Group 4 
None 
(chemical 
control) 
Group 5 
None 
(infectious 
control) 
3 Feed chemicals started (Groups 1, 2, 3); bovine virus diarrhea vaccination -- 16 calves, 
4 in each of Groups 1, 2, 3, 4 
4 Haemophilus somnus-infectious bovine rhinotracheitis challenge -- 32 calves, 8 in each of 
Groups 1, 2, 3, 4 
5 
6 
7 
Period 3 (5 weeks) 
8 Foot rot challenge (Spherophorus necrophorus and Bacteriodes melaninogenicus) -- 16 calves, 
2 bovine-virus-diarrhea vaccinated and 2 nonvaccinated, in each of Groups 1, 2, 3, 4 
9 
10 
N 
0 
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bodies or at least had the lowest titers. The other 4 calves in each group 
were designated vaccination controls. The 2-ml dose of BVD vaccine pro-
duced 2 X 104 plaque forming units (PFU)/ml; 
One week after BVD vaccination, the first 4 groups were challenged 
with !!· somnus and IBR virus using nasal spray administration (Table 1). 
The .!!· somnus-IBR virus mixture had 1 X 106 PFU/ml of IBR virus and 5 X 105 
!!· somnus cells/ml. A total suspension of 5 ml was divided in 2 aliquots 
of 2.5 ml each for spraying in each nostril. 
After 2 weeks, 2 heifers in each of the 5 groups were inoculated with 
an H.· somnus suspension by the intravenous route. This suspension con-
tained 2.23 X 104 !!· somnus cells/ml. 
At the end of the third week during Period 3, 4 animals (2 BVD vacci-
nated and 2 nonvaccinated) from Groups 1, 2, 3, and 4 were inoculated with 
foot rot bacteria, a mixture of .2_. necrophorus and Ji. melaninogenicus. 
This mixture had equal concentrations of both species in a 3-ml volume that 
was injected by the intradermal, interdigital route. 
The challenge schedule for foot rot was as follows: 
Left front foot .2_. necrophorus plus 11· melaninogenicus strain "A". 
!,tlt ~ foot .§.. necrophorus plus 11· melaninogenicus strain "B". 
Right~ foot 11· melaninogenicus only (3 ml). 
Right front foot Uninoculated control. 
E. Bacterial and Viral Isolations 
1. Bacterial isolations 
Two nasal swabs were taken from each heifer at the end of the first 
and second weeks before any infectious agent was inoculated. Nasal swabs 
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were again collected 1, 2, and 3 weeks after the challenge period had 
started. Nasal swabs were tested for aerobic and anaerobic bacteria. 
Those bacteria that were considered pathogenic due to colony shape were 
either stained or streaked in selective growth media and biochemically dif-
ferentiated. 
2. Haemophilus somnus isolations 
!!· somnus isolations were attempted on blood agar from nasal swabs 
(Brown .!!.!:. &·, 1970b). Blood agar plates were streaked and 'incubated at 
37°C anaerobically for about 24 hours; after the inoculation period, small, 
transparent colonies were sought. Confirmation of!!· somnus colony sus-
pects required Gram staining and differential growth media or biochemical 
assays. 
3. Infectious bovine rhinotracheitis virus isolations 
One and 3 weeks after IBR virus challenge, attempts were made to 
recover IBR virus from nasal swabs. Primary bovine testicle cell cultures 
were inoculated. Cells in a confluent monolayer of 60 X 15 ml Falcon 
-1 
tissue culture bottles were exposed to 10 and 10 dilution of inoculum. 
This inoculum was previously treated with antibiotics. After a 30-minute 
incubation period, plates were overlayed with agar. The IBR plaques 
appeared in approximately 2 days. 
F. Serology 
Attempts were made to monitor the immune response of the BVD vacci-
nated and nonvaccinated animals that were subsequently challenged by !BR 
virus and !!· somnus bacteria. 
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Serum specimens were collected according to the following schedule: 
1 and 2 weeks before any artificial infectious agent exposure; at 1, 2, 3, 
4, 6, 7, and 10 weeks following BVD vaccination (1, 3, 5, 6, and 9 weeks 
following the IBR exposure). BVD and IBR antibodies were titered according 
to the technique used at the Iowa State University Veterinary Diagnostic 
Laboratory (Brown~ !!l·• 1970b). The serum samples were screened at a 
final dilution of 1:16 to detect specific BVD virus neutralizing activity 
and 1:128 to detect IBR virus neutralizing activity. A positive result was 
recorded. for specimens which neutralized.SO percent or more of the respec-
tive test virus as compared to controls. End titers were not determined. 
!!.· somnus antibodies were titered by the microtiter adaptation of the 
complement fixation test (Brown et !!l·, 1970b) using serial 2-fold dilutions 
of sera taken according to the schedule established following IBR virus 
challenge. These serum samples were tested against a standard 1:30 dilu-
tion of sonicated !!.· somnus antigen. The results reported are the recipro-
cal of the highest dilution which exhibited 50 percent or greater inhibi-
tion of hemolysis. 
G. Clinical Signs 
Each lot of cattle was observed for signs of clinical illness. Clini-
cal signs for each animal were recorded about 30 minutes before and after 
the feeding time. Two recordings of clinical signs were made each day, the 
first between 8:00-9:00 a.m. and the second between 4:00-5:00 p.m. 
Body temperatures and weights were measured before each of the 8 times 
that blood samples were taken. Special care was taken following exposure 
to IBR virus to note mucus nasal discharge, lacrimation, and coughing. 
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Following challenge with foot rot agents, the incidences of lameness, 
swelling of the lower extremities of the limbs, and interdigital lesions 
were recorded. 
H. Clinical Pathology 
Clinical chemistry and hematologic studies were done in all groups. 
Serum glutamic oxaloacetic transaminase (SGOT) and blood urea nitrogen 
(BUN) values, indicative of liver degeneration and renal function, respec-
tively, were deter~mined twice during Period 1 and 6 times during Periods 2 
and 3. 
1. Packed~ volume 
Packed red blood cell volumes were assayed utilizing the microhemato-
crit technique (McGovern~ al., 1955). 
2. White blood cell count 
White blood cell counts were determined using whole blood diluted with 
6 a 2 percent solution of acetic acid to remove the erythrocytes. 
3. Plasma proteins 
7 Plasma proteins were analyzed using a refractometer. 
6 
Coulter electronic cell counter, Model F, Coulter Electronics, Inc., 
Hialeah, Florida. 
7 
TC/refractometer concentrimeter, American Optical Co., Buffalo, New 
York. 
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4. Fibrinogen 
Fibrinogen was quantitated in plasma fluid once plasma proteins had 
been quantitated. The same refractometer was used for fibrinogen and 
plasma proteins measu_rements. 
5. Blood~ nitrogen 
Whole blood was mixed in commercially prepared test tubes containing 
potassium ethylenediaminetetracetate (EDTA) as anticoagulant and assayed 
for blood urea nitrogen using the colorimetric Berthelo's reaction. 8 
6. Serum glutamic oxaloacetic transaminase 
Serum glutamic oxaloacetic transaminase was determined in serum sam-
ples colorimetrically. 9 
7. White blood cell differentials 
White blood cells differentials were done on blood smears stained by 
Wright's method (Coles, 1967). They were examined under oil immersion of a 
light microscope. 
I. Chemical Analyses 
Chemical analyses for ammonia nitrogen (NH
3
-N) and total blood iodine 
were conducted in those groups given urea, EDDI, and in the chemical con-
trol group. 
8
BUN test, Bio-Dynamics, Inc., Indianapolis, Indiana. 
9 
Dade Division, American Hospital Supply Co., Miami, Florida. 
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1. Blood ammonia nitrogen 
Blood ammonia nitrogen values were determined twice during Period l 
and 5 times during Periods 2 and 3 using a modification of Conway's.micro-
diffusion method (Conway, 1957; Lloyd, 1970). 
2. Total blood iodine 
Total blood iodine values were determined twice before EDDI adminis-
tration was commenced and 6 times during the feeding trials. Analyses were 
conducted in both groups receiving EDDI and the infectious control group. 
The analyses were done by Whitmoyer Laboratories 10 using a procedure based 
on the method described by Benotti and Benotti (1963). 
J. Analyses of Data 
Mean values for all parameters were plotted on a curve design, as 
shown in Figures 1-14. The 10 weeks of the experiment were divided into 
the 3 periods previously described. Mean values of each period for each 
parameter in each group were computed. A student t test for analysis 
between 2 groups at 1 specific period was performed. For this approach, 
values that showed a gross difference were selected. Period 2 of Group 2 
was selected as a main point of reference, due to the fact that it cor-
responded to high EDDI levels, However, any differences between other 
groups and periods were examined. 
lOMethod 690-0, Whitmoyer Laboratories, 1963. 
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IV. RESULTS AND DISCUSSION 
Data from this project are grouped around 5 primary categories: 
(1) clinical signs, (2) performance, (3) serologic and microbiologic isola-
tions (bacterial and viral), (4) clinical pathology studies, and (5) .chemi-
cal analyses. A complete tabulation of data from each of the parameters 
investigated is presented in the Appendix. 
A. Clinical Signs 
The incidence of coughing, nasal discharge, and lacrimation was 
recorded during Period 2 (21 days). All animals in all groups given 0, 
50 mg EDDI plus 0.1 lb urea/head/day, 500 mg EDDI/head/day, and 0.1 lb 
urea/head/day coughed during the week following IBR virus-H. somnus chal-
lenge (Appendix Figure 1). Those receiving 500 mg EDDI, however, had a 
greater incidence of coughing before challenge which lasted longer follow-
ing challenge than the other groups, and those receiving 50 mg EDDI plus 
0.1 lb urea had a somewhat greater incidence of coughing than the group 
receiving urea alone and the control group. 
All animals given 500 mg EDDI/head/day had nasal discharge within 
1 week following IBR virus-!!. somnus challenge, whereas only 50 percent of 
those given 0.1 lb urea and those given 50 mg EDDI plus 0.1 lb urea exhib-
ited nasal discharge during this period (Appendix Figure 2). Also, those 
given 500 mg EDDI exhibited an increased incidence of nasal discharge a few 
days prior to and the week following challenge with IBR virus and!!· somnus. 
Approximately'50 percent of those animals given 500 mg EDDI/head/day 
exhibited lacrimation for about 7 days, beginning 1 week after IBR virus 
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and.!!.· somnus challenge (Appendix Figure 3). Those given O, 50 mg EDDI, 
and 0.1 lb urea also manifested lacrimation but to a lesser extent. 
The above mentioned clinical signs, i.e., coughing, nasal discharge, 
and lacrimation, reflect not only the expectorant effects of EDDI but also 
those of a respiratory viral infection such as IBR. In all animals, signs 
were more pronounced during the period of peak IBR infection approximately 
7-14 days following challenge. Most of the clinical signs ceased within 
3 days after removal of EDDI from the diet, including in the control group 
that received no EDDI and the group that received 0.1 lb urea. Signs of 
.!!.· somnus infection were not observed. 
Clinical signs of experimental foot rot commenced 2 to 4 days after 
inoculation in those groups receiving 50 mg EDDI daily (Groups 2 and 3) as 
well as those not receiving EDDI (Groups 1 and 4) (Table 2). Clinical 
signs commenced 2-4 days after inoculation. Six of 8 animals experienced 
lameness, swelling of the lower left front and rear legs, and interstitial 
necrotic pododermatitis at the site of inoculation. These signs were 
observed for 4 days but subsided after antibiotic treatment. The right 
front feet (uninoculated) were unaffected as were all feet of those animals 
that were not inoculated with the foot rot agents. 
Both groups of calves being given 50 mg EDDI/head/day contracted "foot 
rot" (pododermatitis) within 2-3 days following inoculation by 
.§_. necrophorus and .!l.· melaninogenicus suspensions, as did those animals not 
receiving EDDI. This phase of the study is inconclusive, however, because 
a very large inoculum of .§_. necrophorus and .!l.· melaninogenicus was used, 
and test animals were receiving only 50 mg EDDI/head/day. Other experimen-
tation should include studies with animals given 500 mg EDDI/head/day at 
Table 2. Incidence of clinical signs in calves fed EDDI, urea, and no feed additives following 
interdigital-intradermal inoculation of Spherophorus necrophorus and Bacteriodes 
melaninogenicusa 
Clinical 
signs 
Lameness 
Swelling of 
inoculated 
feet 
Necrotic 
pododerma-
ti tis 
Group 1 
Urea 
0.1 lb/hd/dy 
8 weeks 
Group 2 
EDDI 
500 mg/hd/dy 
3 weeks; 
50 mg/hd/dy 
5 weeks 
Chemicals in feed 
Group 3 
EDDI-Urea 
50 mg EDDI/hd/dy-
0.1 lb urea/hd/dy 
8 weeks 
Days after challenge clinical signs observed 
2-4 2-6 
(2/4)b (3/4) 
2-5 
(3/4) 
2-4 2-6 2-5 
(2/4) (3/4) (3/4) 
2-4 2-6 2-5 
(2/4) (3/4) (3/4) 
Group 4 
None 
(chemical 
control) 
4-6 
(3/4) 
4-6 
(3/4) 
4-6 
(3/4) 
Group 5 
None 
(infectious 
control) 
Not 
challenged 
a . Animals were inoculated at the beginning of the third week of Period 3 (2 weeks after Group 2 
EDDI exposure had been reduced to 50 mg/hy/dy). 
b 
Numbers in parentheses indicate number of affected animals of the total challenged in the 
group. 
N 
"' 
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the time of bacterial inoculation, and various dosage levels of inoculum 
should be used to adequately determine the effectiveness of EDDI as a pre-
ventative and treatment for foot rot. 
In Group 4, not given EDDI, clinical signs commenced 3 to 4 days after 
inoculation and lasted 2 to 4 days. Three of 4 animals had affected left 
rear feet, 2 had affected left front feet, and 1 had affected right rear 
foot but to a lesser degree. Antibiotic treatment was given to those ani-
mals most severely affected, and recovery was usually within 2 days. 
Only 2 borderline foot rot cases were detected in Group 1, giveIJ. urea 
(0.1 lb/head/day) with no EDDI. The rear feet on both animals were 
affected for 2 days. ~Interdigital lesions consisted of superficial skin 
necrosis which healed 2 days later. No antibiotic treatment was'given. 
1. Body temperature 
No statistically significant differences were found in mean body tem-
peratures in calves exposed to both levels of EDDI, urea, and the controls 
(Appendix Figure 4). A significant difference in mean body temperature 
occurred during Period 1 when no EDDI or urea was being fed. Calculated 
T (Tc) and tabulated T (Tt) of the chemical control group (Group 4) and the 
500 mg EDDI/head/day group (Group 2) during Period 1 were 3.26 and 1.69, 
respectively. A similar difference was also seen between the infectious 
control group (Group 5) and Group 2 during Period 2 (Tc = 3.3 and Tt = 
1.69), but it was considered null because of the prior difference seen dur-
ing Period 1 when no EDDI and urea were fed. The changes in body tempera-
ture in any of the groups during any week were not significant when com-
pared to those changes experienced by other groups. 
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B. Body Weight Gain 
Body weights of the calves measured during the 10-week period are sum-
marized in Appendix Figure 5 and detailed in Appendix Table 1. Their over-
all mean weight was 423 lb at the beginning and 540 lb after 10 weeks on 
- the experiment. Their average daily gains (pounds) during the 10-week 
experiment were as follows: Group 1, 1.79; Group 2, 1.56; Group 3, 1.53; 
Group 4, 1.97, and Group 5, 1.70. 
An F test was performed to determine if the weight gains in all 5 
groups were significantly different (Appendix Figure 5). 
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F = 4,33 520 = 
1.21 which is not significant. There is no evidence that the gain in 
weight differed significantly among the 5 groups. 
C. Microbiologic Isolations and Serology 
Antibodies for !BR virus were not present in any of the calves before 
the experiment was begun and remained undetectable through the second we~k 
after challenge. !BR was confirmed by isolation of the virus from random 
blood samples taken from affected animals. Subsequent antibody titrations 
indicated that a general !BR infection had occurred in all 4 groups. 
Within 3 weeks after !BR virus exposure, antibodies were detected in 17 of 
32 of the experimentally exposed calves (Table 3, Appendi"' Table 3). It is 
noteworthy that 3 calves in Group 2 and 1 animal in each of Groups 1 and 4 
failed to develop detectable circulating iBR antibodies, even though these 
animals were clinically indistinguishable from the other affected calves 
which developed antibodies. This is not too surprising, however, in light 
of previous reports of variations in circulating antibodies in convalescent 
animals (McKercher and Straub., 1960). 
Table 3. Infectious bovine rhinotracheitis antibody titers (before and after challenge) in calves 
fed EDDI, urea, and no feed additives (8 animals in each of Groups 1, 2, 3, 4 were chal-
lenged) 
Week 
1 
2 
3 
4 
5 
Group 1 
Urea 
0.1 lb/hd/dy 
8 weeks 
8/0a 
8/0 
8/0 
8/0 
4/4 
Group 2 
EDDI 
500 mg/hd/dy 
3 weeks; 
50 mg/hd/dy 
5 weeks 
8/0 
8/0 
8/0 
Chemicals in feed 
Group 3 
EDDI-Urea 
50 mg EDDI/hd/dy-
0.1 lb urea/hd/dy 
8 weeks 
8/0 
8/0 
8/0 
Infectious bovine rhinotracheitis challenge 
8/0 
5/3 
8/0 
3/5 
Group 4 
None 
(chemical 
control) 
8/0 
8/0 
8/0 
8/0 
6/2 
Group 5 
None 
(infectious 
control) 
8/0 
8/0 
8/0 
8/0 
8/0 
------- ------- -------
6 4/4 5/3 2/6 4/4 8/0 
8 4/4 5/3 2/6 2/6 7/1 
10 3/5 7 /1 4/4 6/2 8/0 
a Numerator indicates number of animals negative to infectious bovine rhinotracheitis antibodies 
at a 1:16 serum dilution; denominator indicates number of animals with positive titers above 1:16 
serum dilution. 
w 
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Since a majority of the calves were found to have circulating anti-
bodies for BVD virus (Table 4, Appendix Table 4) and g. somnus bacteria 
prior to BVD vaccination and subsequent challenge to IBR-g. somnus agents, 
enhancement of _!!. somnus infectivity by BVD vaccination was not expe.cted. 
This indeed was the case based upon the following observations: (1) white 
blood cell counts did not decrease in the vaccinated calves, (2) the clini-
cal signs observed subsequent to IBR-g. somnus challenge were not indica-
tive of g. somnus ·infection, .and (3) g. somnus bacteria were not isolated 
from the blood of affected animals although attempts were made to do so. 
It is apparent, however, that both BVD vaccination and :!!· somnus challenge 
stimulated the production of their respective circulating antibodies 
(Tables 4 and 5, Appendix Tables 4 and 5). Although serum dilutions were 
not extended beyond 1:16, it is evident that the BVD-vaccinated calves had 
circulating antibodies for a longer time than the nonvaccinated calves. 
The bacteria isolated from nasal swabs are listed below (only the 
pathogenic bacteria are included: 
The first nasal swab sampling taken 1 week after BVD vaccination 
resulted in I· multocida isolation from only 1 animal from each of Groups 
1, 3, 4, and 5. After 2 weeks, I· multocida was isolated from 2 nasal 
swabs from Group 4, from 3 nasal swabs of Group 3, and from only 1 from 
Groups 1, 3, and 5. Hemolytic streptococci and moraxella were isolated 
from nasal swabs of Group ·4 after 3 weeks. From a sampling after 4 weeks, 
f· multocida was isolated from 6 nasal swabs from 2 animals in each of 
Groups 2, 3, and 4. A week after exposure, !!· somnus was recovered from 
nasal swabs from Groups 2 and 3. 
Table 4. Bovine virus diarrhea antibody titers in calves receiving EDDI, urea, and no feed additives 
(4 animals in each of Groups 1, 2, 3, 4 were vaccinated with BVD virus) 
Week 
-
-
1 
2 
-
3 
4 
5 
-
6 
8 
10 
- - - -
- - - -
-
-
Group 1 
Urea 
0.1 lb/hd/dy 
8 weeks 
- -
- -
l/7a 
0/8 
1/7 
2/6 
4/4 
2/6 
4/4 
4/4 
-
- -
- - - -
- - - -
Group 2 
EDDI 
500 mg/hd/dy 
3 weeks; 
50 mg/hd/dy 
5 weeks 
5/3 
0/8 
-
Bovine 
-
1/7 
3/5 
4/4 
3/5 
4/4 
5/3 
- -
virus 
- -
-
-
-
Chemicals in feed 
Group 3 
EDDI-Urea 
50 mg EDDI/hd/dy-
0.1 lb urea/hd/dy 
8 weeks 
4/4 
0/8 
- - - - - - -
diarrhea vaccination 
- - - -
1/7 
3/5 
4/4 
4/4 
4/4 
4/4 
- - - - - -
Group 4 
None. 
(chemical 
control) 
-
3/5 
1/7 
0/8 
1/7 
4/4 
4/4 
4/4 
4/4 
-
-
- - -
- - -
-
-
Group 5 
None 
(infectious 
control) 
- -
- -
3/5 
1/7 
2/6 
4/4 
6/2 
7 /1 
8/0 
7 /1 
aDenominator denotes number of animals positive to bovine virus diarrhea antibodies at a 1:16 
dilution; numerator denotes the.number of animals with a bovine virus diarrhea antibodies titer below 
1:16 serum dilution. 
w ..,.. 
Table 5. Haemoehilus somnus antibody titers (before and after challenge) in calves fed EDDI, urea, 
and no feed additives (8 animals in each of Groups 1, 2, 3, 4 were challenged· 
Week 
1 
2 
3 
4 
5 
Group 1 
Urea 
0.1 lb/hd/dy 
8 weeks 
l/7a 
1/7 
0/8 
0/8 
0/8 
Group 2 
EDDI 
500 mg/hd/dy 
3 weeks; 
50 mg/hd/dy 
5 weeks 
1/7 
0/8 
1/7 
Chemicals in feed 
Group 3 
EDDI•Urea 
.50 mg EDDI/hd/dy-
0.1 lb urea/hd/dy 
8 weeks 
2/6 
1/7 
0/8 
Haemophilus somnus challenge 
1/7 0/8 
2/6 0/8 
Group 4 
None 
(chemical 
control) 
2/6 
0/8 
0/8 
0/8 
0/8 
Group 5 
None 
(infectious 
control) 
0/8 
1/7 
0/8 
0/8 
0/8 
- - - - - - - - - ------- ------- ------- - - - - - - -
6 0/8 1/7 1/6 0/8 0/8 
8 0/8 2/6 0/8 0/8 0/8 
10 0/8 3/5 0/8 0/8 0/8 
a 
Denominator denotes number of animals positive to Haemophilus somnus antibodies at a 1:8 serum 
dilution; numerator denotes number of animals with a Haemophilus somnus antibodies titer below 1:8 
serum dilution. 
w ..,, 
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Although an objective of this experiment was to produce a complex !BR-
!!· sornnus infection, this was not accomplished because the calves were 
immune to both BVD and!!· somnus agents, Therefore, an uncomplicated !BR 
infection was produced in these calves. 
D. Clinical Pathology Studies 
1, Serum glutamic oxaloacetic transaminase 
During the entire experiment, serum glutamic oxaloacetic transaminase 
groups were consistently within the normal range, and no statistically sig-
nificant differences were found among the groups (Appendix Figure 6, Appen-
dix Table 6). 
2. Blood ~ nitrogen 
Variations in blood urea nitrogen values in animals among the 5 groups 
and at any specific time were not statistically significant during the 
10-week experiment (Appendix Figure 7, Appendix Table 7). 
3. Hematologic studies 
There were not statistically significant differences among the 5 
groups in white blood cell count, lymphocytes, segmented and band neutro-
phils, eosinophils, and packed cell volume values (Appendix Figures 8, 9, 
10, 11, 12, 14). At the eighth week of the experiment (6 weeks of exposure 
to EDDI and urea), there were significant increases (TC= 2.75; Tt = 1.96) 
in mean fibrinogen and corresponding total protein values in all except the 
2 control groups. Not all individuals within a group had increased values 
(Appendix Figures 14 and 15, Appendix Tables 15 and 16), and this phenome-
non has not been explained. At this point in the experiment, the respira-
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tory infection has completely subsided, and those on EDDI were being given 
only 50 mg/head/day. One possible attributing factor was a severe snow-
storm (36-hour blizzard) which occurred 1 week before the increased fibrin-
ogen-total protein levels were detected. 
E. Chemical Analyses 
1. Blood ammonia nitrogen 
The blood ammonia nitrogen levels are not reported because laboratory 
errors resulted in erratic and unacceptable data. It was determined that 
glassware used in the test had been cleaned with an alkaline detergent and 
was not properly rinsed, resulting in inordinately high and erratic levels 
of sulfuric acid necessary for titration to the neutral end point required 
in the test procedure. 
2. Total blood iodine 
Total blood iodine levels were significantly increased in those groups 
given EDDI. The mean levels peaked at 1400 ng/ml after 2 weeks in the 
500 mg/head/day group, whereas those on 50 mg/head/day peaked at about 
300 ng/ml. When EDDI exposure was maintained at 50 mg/head/day (Groups 2 
and 3), the total blood iodine levels remained slightly under 275 ng/ml, and 
the control animals (Group 5) averaged 140 ng/ml. 
Differences in mean total blood iodine levels were highly significant 
between EDDI groups and the controls. Total blood iodine levels compared 
between Group 2 Period 2 to Group 5 Period 2 had the following T values: 
Tc= 66 and Tt = 1.96; Group 3 (50 mg EDDI plus 0.1 lb urea/head/day). 
Period 3 compared to Group 5 Period 3 had Tc = 8.07 and Tt = 1.96. 
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V. CONCLUSIONS 
Attempts to confirm field observations that cattle suffering adverse 
effects from bovine virus diarrhea (BVD) vaccination and concomitant expo-
sure to infectious bovine rhinotracheitis (IBR) virus and Haemophilis somnus 
bacteria were unsuccessful since this group of calves were already resis• 
tant to BVD and !!.· somnus infection. Antibody titers before BVD vaccina-
tion and !!.· somnus challenge were inconsistent but present in all the 
calves, although only a maximum serum dilution of 1:16 was titrated. 
No adverse effects from BVD vaccination were demonstrated. Immunosup.-
pression and delayed hypersensitivity reactions were not associated with 
BVD vaccination and!!.· somnus-IBR virus challenge. 
This group of calves was susceptible to IBR virus infection. No anti-
bodies were present before IBR challenge, but 2 weeks later antibody titers 
were consistently present in all exposed calves. A natural spread of the 
disease was evident and confirmed by IJlR virus isolation from blood and 
nasal swabs of challenged and control groups. 
Clinical signs manifested by the calves were indicative of both the 
expectorant action of EDDI and IBR infection. Those animals given 500 mg 
EDDI/head/day had more coughing, nasal discharge, and lacrimation than 
those given 50 mg EDDI/head/day or 0.1 lb urea/head/day or the controls. 
The period of time required for recovery from IBR infection, however, 
appeared to be about the same in the EDDI exposed, those fed 0.1 lb urea/ 
head/day, and the control animals. 
Mean temperature changes experienced by this herd of calves were not 
significantly different at any week neither among groups. Mean weight 
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gains rate was not significantly different among any groups neither at any 
week. 
The replacement of natural dietary protein with 0.1 lb urea/head/day 
in these calves did not appear to affect their susceptibility to or the 
course of !BR infection. 
This report has attempted to distinguish between epidemic foot rot or 
suppurative polyarthritis, a sequellae to !!.· somnus infection, and "true" 
foot rot or infectious pododermatitis produced by the interaction of 
Spherophorus necrophorus and Bacteriodes melaninogenicus when introduced 
intradermally into the interdigital space. Classical foot rot lesions were 
produced in 14 of 16 animals inoculated with a suspension of these 2 bac-
terial species. Calves given 500 mg EDDI/head/day for 3 weeks followed by 
50 mg/head/day and calves given 50 mg/head/day for 6 weeks were equally 
susceptible to pododermatitis infection by §.. necrophorus and Jl.. melanino-
genicus as the non-EDDI controls. This experiment is inconclusive and 
should be repeated using different levels of EDDI as well as varied numbers 
of bacteria in suspension. In our experiments, a high concentration of 
organisms was used for the inoculum, and only 50 mg EDDI/head/day were 
given. Other experimentation should include studies with animals given 
500 mg EDDI/head/day at the time of bacterial inoculation. 
Other experimentation should include studies with animals given 500 mg 
EDDI/head/day at the time of bacterial inoculation,. and various dosage lev-
els of inoculum should be used to adequately determine the effectiveness of 
EDDI as a preventative or treatment for foot rot. 
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VI. SUMMARY 
Forty crossbred beef calves weighing an average of 423 lb each were 
placed in 5 lots consisting of 8 animals/group. Each group was fed a basal 
ration consisting of concentrate and alfalfa hay. The concentrate was made 
up of corn and soybean oil meal plus minerals and vitamins. Three groups 
were given urea and ethylenediamine dihydriodide (EDDI) in their diet as 
follows: Group 1 was given 0.1 lb urea/head/day for 56 days in place of an 
equivalent amount of natural protein; Group 2 was given 500 mg EDDI/head/ 
day for 21 days, followed by 50 mg EDDI/head/day for an additional 35 days; 
Group 3 was given 0.1 lb urea/head/day as a replacement for an equivalent 
amount of natural protein and 50 mg EDDI/head/day for 56 days; and Groups 4 
and 5 were given basal rations with no chemical additives and served as 
chemical control and infectious control, respectively. 
The 10-week experiment was divided into 3 periods as follows: Period 
1--2 weeks of acclimatization prior to the adding of EDDI and urea to the 
basal ration; Period 2--the following 3 weeks during which Group 2 was 
given 500 mg EDDI/head/day; and Period 3--the remaining 5 weeks during 
which Groups 2 and 3 were given 50 mg EDDI/head/day. 
At the beginning of Period 2, 16 calves, 4 from each of Groups 1, 2, 
3, and 4, were given bovine virus diarrhea (BVD) vaccine. One week later, 
all 32 calves in Groups 1, 2, 3, and 4 were challenged with infectious 
bovine rhinotracheitis (IBR) virus and Haemophilus somnus bacteria in an 
attempt to produce a shipping fever-like respiratory infection. Group 5 
remained as an unexposed contro 1. 
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At the beginning of the third week of Period 3, 4 animals (2 BVD vac-
cinated and 2 nonvaccinated) from Groups 1, 2, 3, and 4 were inoculated 
with a mixture of Spherophorus necrophorus and Bacteriodes melaninogenicus 
in an attempt to produce classical foot rot, infectious pododermatitis. 
The inoculum was injected intradermally in the interdigital spaces of the 
left front and rear feet. The right rear foot was injected with a culture 
of !!.· melaninogenicus only, and the right front foot of each animal 
remained as an uninoculated control. 
All animals given IBR virus developed clinical signs of the disease 
within 7 days. No signs of!!· somnus infection were obeerved. Clinical 
signs were primarily manifested by coughing, nasal discharge, lacrimation, 
and temperature rise. Those animals receiving 500 mg EDDI/head/day were 
coughing and had nasal discharge sooner than and for a .more prolonged 
period of time than animals"in the other groups. Also, those animals 
receiving 50 mg EDDI/head/day had a slightly increased incidence of cough-
ing and nasal discharge over those animals receiving no EDDI. There were 
no significant differences in temperature elevations, weight gain, clinical 
pathologic, and hematologic parameters measured between those animals given 
EDDI and/or urea and the controls. 
It was concluded that coughing, nasal discharge, and lacrimation 
reflected not only the expectorant effects of EDDI but also those of a res-
piratory viral infection such as IBR. Even though these clinical signs 
were more pronounced in the high EDDI exposed group, the overall outcome of 
IBR infection was essentially the same in all groups of animals, whether 
exposed to EDDI or not. Although the study was not designed to be a feed-
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ing trial, average daily weight gains were not statistically different 
among the 5 groups of calves. 
The total blood iodine levels peaked at the end of the second week of 
feeding EDDI. Those calves given 500 mg EDDI/head/day reached a mean total 
blood iodine level of 1,400 ng/ml while those receiving 50 mg EDDI/head/day 
reached a peak of 330 ng/ml. The control animals also had slight increases 
in total blood iodine, reaching a peak of 142 ng/ml. This finding reflects 
the ease with which iodine may contaminate the environment by urine, feces, 
and perhaps feed dust. 
Both groups of calves being given 50 mg EDDI/head/day contracted "foot 
rot" (pododermatitis) within 2-3 days following inoculation by 
§.. necrophorus and Jl.. melaninogenicus suspensions, as did those animals not 
receiving EDDI. This phase of the study is inconclusive because a very 
large inoculum of §.. necrophorus and Jl.. melaninogenicus was used, and test 
animals were receiving only 50 mg EDDI/head/day. 
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IX. APPENDIX 
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Figure 1. Percent incidence of coughing in experimental and control calves (8 animals per group) 
during Period 2 (21 days) (see Table 1 for experimental paradigm) 
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Figure 2. Percent incidence of nasal discharge in experimental and control calves (8 aniinals per 
group) during Period 2 (21 days) (see Table 1 for experimental paradigm) 
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Figure 3. Percent incidence of lacrimation in experimental and control calves (8 animals per group) 
during Period 2 (21 days) (see Table 1 for experimental paradigm) 
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Figure 4. Weekly mean body temperatures in experimental and control calves (8 anima'1s per group) 
during the 10-week experiment (see Table 1 for experimental paradfgm) 
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Figure 5. Weekly mean body weights in experimental and control calves (8 animals per group) during 
the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 6. Weekly mean serum glutamic oxaloacetic transaminase activities in experimental and con-
trol calves (8 animals per group) during the 10-week experiment (see Table 1 for experi-
mental paradigm) 
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Figure 7. Weekly mean blood urea nitrogen levels in experimental and control calves (8 animals per 
group) during the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 8. Weekly mean white blood cell counts in experimental and control calves (8 animals per 
group) during the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 9. Weekly mean lymphocytes (percent) in.experimental and control calves (8 animals per group) 
during the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 10. Weekly mean segmented neutrophils (percent) in experimental and control calves (8 animals 
per group) during the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 11. Weekly mean band neutrophils (percent) in experimental and control calves (8 animals per 
group) during the 10-week experiment (see Table 1 for experimenta~ paradigm) 
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Figure 12. Weekly ·mean eosinophils (percent) in experimental and control calves (8 animals per 
group) during the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 13. Weekly mean packed cell volumes in experimental and control calves (8 animals per group) 
during the 10-week experiment (see Table l for experimental paradigm) 
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Figure 14. Weekly mean fibrinogen levels in experimental and control calves (8 animals per group) 
during the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 15. Weekly mean total plasma protein levels in experimental and control calves (8 animals per 
group) during the 10-week experiment (see Table 1 for experimental paradigm) 
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Figure 16. Weekly mean total blood iodine levels in experimental and control calves (8 animals per 
group) during the 10-week experiment (see Table 1 for experimental paradigm) 
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Table Al. Body weight -- pounds 
Weeks of chemical ex2osure 
Animal Period l Period 2 Period 3 
Group number -1 0 l 2 3 4 6 8 
Group l 8 420 453 475 483 489 489 500 539 
Urea 13 383 400 405 386 402 396 -- 435 
0.1 lb/hd/dy 15 391 444 ·444 455 472 476 481 526 
8 weeks 34 434 473 469 479 493 492 510 549 
35 466 512 505 508 519 530 545 583 
36 408 452 459 457 472 488 502 570 
38 422 444 441 451 477 490 505 535 
40 390 434 440 456 465 474 484 544 
Group 2 17 484 500 517 535 530 542 559 597 00 N 
EDDI 18 355 390 383 395 401 397 414 458 
500 mg/hd/dy 19 447 426 430 441 453 455 475 514 
3 weeks; 25 530 570 570 590 598 600 622 
50 mg/hd/dy 26 446 470 472 499 509 501 538 594 
5 weeks 28 335 379 385 400 414 415 547 480 
31 456 457 455 459 454 457 491 523 
32 349 379 375 374 388 388 407 447 
Group 3 4 449 462 490 485 500 512 520 524 
EDDI-Urea 6 457 463 494 515 525 -- 560 560 
50 mg EDDI/hd/dy- 20 321 365 404 353 365 375 390 421 
0.1 lb urea/hd/dy 21 447 463 476 474 498 508 517 550 
8 weeks 22 485 557 565 560 571 585 593 630 
23 436 475 478 477 490 494 517 557 
24 550 590 576 576 548 594 601 613 
27 410 455 472 475 485 492 508 555 
Table Al. (Continued) 
Weeks of chemical exposure 
Animal Pe-riod l Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 4 2 418 425 455 468 473 490 497 534 
-- None 3 410 429 440 477 470 475 502 552 
(chemical 5 426 440 479 514 512 530 541 605 
control) 11 429 489 514 521 514 540 560 602 
12 493 535 517 540 555 562 572 621 
16 424 458 465 483 495 491 521 560 
37 418 428 434 451 455 458 469 517 
39 439 444 476 492 502 519 528 574 
Group 5 l 429 465 470 488 501 524 554 
C1> -- w 
None 7 429 473 471 465 493 503 546 580 
(infectious 9 346 395 391 476 410 422 449 491 
control) 10 450 484 476 415 479 478 509 536 
14 390 455 444 401 473 475 513 540 
29 449 470 460 489 494 498 524 535 
30 397 415 390 402 419 433 463 482 
33 380 402 390 472 413 423 460 484 
Table A2. Temperature (degrees Fahrenheit) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group numbe·r -1 0 1 2 3 4 6 8 
Group 1 8 102.5 102.0 102.4 102.2 101.6 101.2 102.8 102.6 
Urea 13 103.3 103.0 103.0 102.4 102.8 102.6 102.2 
0.1 lb/hd/dy 15 102.7 103.0 102.0 102.8 101.0 102.0 102.8 102.0 
8 weeks 34 101. 2 103.4 102.8 102.6 100.2 102.0 103.0 102.8 
35 101.4 103.0 102.2 102.8 102.4 102.6 102.0 102.0 
36 101.4 103.0 103.6 103.8 102.6 103.2 102.6 102.4 
38 103.6 103.0 103.0 102.2 102.0 102.0 102.8 102.6 
40 103.6 103.4 102.6 102.0 101.0 102.0 102.8 102.2 
Group 2 17 102.9 103.0 102.6 102.0 100.8 102.4 102.4 103.2 "' .,. 
EDDI 18 103.6 104.6 102.8 102.8 101.0 103.0 104.4 102.8 
500 mg/hd/dy 19 102.3 102.8 102.6 103.2 102.4 101.2 103.4 101.6 
3 weeks; 25 102.8 104.0 103.4 103.8 101.8 102.0 102.8 
50 mg/hd/dy 26 102.8 102.6 104.0 102.4 101.8 103.8 103.2 102.6 
5 weeks 28 102. 8 103.0 103.2 105.4 102.0 101.0 102.6 103.0 
31 103.2 103.4 103.4 105.4 102.0 102.2 103.0 101. 8 
32 103. 8 104.0 103.8 103.8 102.0 103.6 102.0 
Group 3 4 103.0 103.0 103.4 102.8 101.8 101.2 102.8 
EDDI-Urea 6 102.4 102.0 103.0 102.0 100.6 102.0 103.0 
50 mg EDDI/hd/dy- 20 102.2 103.0 104.2 102.2 102.0 1:02.2 103.2 103.4 
0.1 lb urea/hd/dy 21 104.2 103.4 102. 2 104.4 103.4 101.2 104.2 102.4 
8 weeks 22 102.5 102.0 102.2 100.8 100.8 106.6 103.0 101.6 
23 102.0 103.4 103.5 102.6 100.8 103.0 102.8 
24 102.6 103.4 103.2 100.4 102.8 103.8 100.8 
27 101.4 102. 6 102.4 103.0 102.2 100.8 103.0 102.4 
Table A2. (Continued) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 4 2 101.4 100.8 102.6 102. 8 102.6 101.0 102.0 103.6 
None 3 102.6 101.8 102.8 100.8 101.4 101.4 102.2 102 .. 4 
(chemical 5 102.8 102.2 102.2 101.8 101.0 101.6 101.8 102.0 
control) 11 102.6 102.8 102.6 102.4 102.4 102.6 102.6 
12 102.6 103.0 102.6 102.0 102.0 101.4 102.6 101. 8 
16 103.0 102.8 102.6 102.4 102.2 101.6 102.4 102.0 
37 103.0 103.0 102.6 102.4 101.8 101.8 103.2 103.0 
39 103.l 102.0 104.0 102.7 101.4 101.0 102.4 101. 8 
Groue 5 1 102.6 103.2 101. 8 102.8 101.8 101.5 102.2 101.2 00 ..,, 
None 7 102.5 102.8 101. 8 100.8 101.4 102.2 102.4 
(infectious 9 102.0 101. 8 102.2 101.8 101.2 102. 8 102.2 
control) 10 104.0 102.2 102.4 102.0 102.8 103.4 102.0 
14 103.6 102.0 102.8 102.4 102.0 101.6 102.4 102.2 
29 101. 9 103.4 102.8 101.6 101.4 101. 8 102.2 102.2 
30 103.2 102.2 102.6 102. 8 102.8 101.8 102.8 102.0 
33 102.0 102.2 102.6 101.0 102. 8 101. 8 102.2 102.4 
Table A3. Infectious bovine rhinotracheitis (IBR) antibody titersa 
Weeks of chemical exEosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
GrouE 1 8 Q 0 0 0 0 0 0 0 
Urea 13 0 0 0 0 16 64 0 
0.1 lb/hd/dy 15 0 0 0 0 16 16 32 16 
8 weeks 34 0 0 0 0 0 0 0 0 
35 0 0 0 0 16 16 32 16 
36 0 0 0 0 16 16 64 32 
38 0 0 0 0 0 0 0 0 
40 0 0 0 0 0 0 16 0 
Group 2 17 0 0 0 0 16 32 16 16 
()) 
°' 
EDDI 18 0 0 0 0 0 0 0 0 
500 mg/hd/dy 19 0 0 0 0 0 0 0 o· 
3 weeks; 25 0 0 0 0 0 0 0 0 
50 mg/hd/dy 26 0 0 0 0 16 0 0 0 
5 weeks 28 0 0 0 0 0 0 16 0 
31 0 0 0 0 16 32 16 0 
32 0 0 0 0 0 16 0 
aTiters expressed as reciprocal of highest serum dilution having a 50 percent reduction in 
plaques forming units (PFU). 
Table A3. (Continued) 
Animal Period 1 
Weeks of chemical exEosure 
Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
GrouE 3 4 0 0 0 0 0 16 64 0 
EDDt-Urea 6 0 0 0 0 0 0 16 0 
50 mg EDDI/hd/dy- 20 0 0 0 0 16 16 16 0 
0.1 lb urea hd/dy 21 0 - 0 0 16 32 64 16 
8 weeks 22 0 0 0 0 0 0 0. 0 
23 0 0 0 0 16 16 16 16 
24 0 0 0 0 32 32 32 32 
27 0 .0 0 0 16 16 0 16 
GrouE 4 2 0 0 0 0 16 32 16 0 00 ..., 
None 3 0 0 0 0 0 16 16 0 
(chemical 5 0 0 0 0 0 0 32 0 
control) 11 0 0 0 0 0 0 32 0 
12 0 0 0 0 0 0 0 0 
16 0 0 0 0 16 64 128 64 
37 0 0 0 0 0 64 0 32 
39 0 0 0 0 0 0 16 0 
GrouE 5 1 0 0 0 0 0 0 0 0 
None 7 0 0 0 0 0 0 0 0 
(infectious 9 0 0 0 0 0 0 0 0 
control) 10 0 0 0 0 0 0 16 16 
No IBR-J!. somnus 14 0 0 0 0 0 0 0 0 
challenge 29 0 0 0 0 0 0 0 0 
30 0 0 0 0 0 0 0 0 
33 0 0 0 0 0 0 ·O 0 
Table A4. Bovine virus diarrhea (BVD) antibody screening results 
Weeks of chemical ex2osure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 1 8 16 16 16 0 0 0 0 0 
Urea 13 16 16 16 16 0 16 0 
0.1 lb/hd/dy 15 16 16 0 16 0 16 0 0 
8 weeks 34 Va 16 16 16 16 16 16 16 16 
35 v 16 16 16 16 16 16 16 16 
36 v 16 16 16 16 16 16 16 16 
38 0 16 16 0 0 0 .o 0 
40 v 16 16 16 16 16 16 16 16 
Group 2 17 v 0 16 16 16 16' 16 16 16 00 00 
EDDI 18 0 16 16 16 0 0 0 0 
500 mg/hd/dy 19 v 0 16 16 16 16 16 16 16 
3 weeks; 25 v 16 16 0 16 16 16 16 
50 mg/hd/dy 26 16 16 16 0 0 16 0 0 
5 weeks 28 16 16 16 0 0 0 o· 0 
31 v 16 16 16 16 16 16 16 16 
32 16 16 16 0 0 0 0 0 
Group 3 4 v 0 16 16 16 16 16 16 16 
EDDI-Urea 6 v 16 16 16 16 16 16 16 
50 mg EDDI/hd/dy- 20 v 16 16 16 16 16 16 16 16 
0.1 lb urea/hd/dy 21 16 16 16 16 0 0 0 0 
8 weeks 22 16 16 16 0 0 0 0 0 
23 v 0 16 16 16 16 16 16 16 
24 0 16 16 0 0 0 0 0 
27 0 16 16 0 0 0 0 0 
8 Indicates animals that were given BVD vaccine at the beginning of Week 1, Period 2. 
Table A4. (Continued) 
Weeks of chemical exEosure 
Animal Period 1 Period 2 · Period 3 
Group number -1 0 1 2 3 4 6 8 
GrouE 4 2 v 0 16b 16 16 16 16 16 16 
None 3 0 16 16 16 0 0 0 0 
(chemical 5 16 16 16 0 0 0 0 0 
control) 11 v 16 16 16 16 16 16 16 16 
12 16 16 16 16 0 0 0 0 
16 16 16 16 16 16 0 0 0 
37 v 0 0 16 16 16 16 16 16 
39 v 16 16 16 16 16 16 16 16 
GrouE 5 1 16 16 16 0 0 0 0 0 00 
"' None 7 16 16 16 16 16 16 0 16 
(infectious 9 16 16 16 16 0 0 0 0 
control) 10 16 16 16 16 0 0 0 0 
14 16 16 16 16 16 0 0 0 
29 0 16 16 0 0 0 0 0 
30 0 16 0 0 0 0 0 0 
33 0 0 0 0 0 0 0 0 
b 
Sera were diluted 1:16 for BVD anitbody screening tests. 
Table AS. a Haemophilus somnus antibody titers 
Animal Period 1 
Group number -1 0 
Group 1 8 8 32 
Urea 13 16 4 
0.1 lb/hd/dy lS 4 16 
8 weeks 34 16 32 
35 8 16 
36 16 32 
38 8 64 
40 16 16 
Group 2 17 16 128 
EDDI 18 8 32 
SOO mg/hd/dy 19 8 32 
3 weeks; 2S 8 64 
50 mg/hd/dy 26 16 16 
S weeks 28 16 32 
31 4 32 
32 16 32 
Group 3 4 16 32 
EDDI-Urea 6 8 16 
SO mg EDDI/hd/dy- 20 8 32 
0.1 lb urea/hd/dy 21 0 0 
8 weeks 22 8 32 
23 8 16 
24 4 16 
27 32' 3Z 
Weeks of chemical e.x:eosure 
Period 2 Period 
1 2 3 4 6 
32 32 64 64 32 
32 16 128 2S6 64 
16 16 16 16 16 
8 8 8 16 16 
8 16 32 32. 16 
16 64 128 64 64 
32 64 16 32 64 
16 32 128 32 32 
32 64 32 32 32 
32 65 32 32 32 
16 32 16 16 16 
4 16 4 16 0 
8 4 4 32 16 
64 128 32 32 16 
16 16 32 32 16 
16 16 8 0 0 
64 128 64 16 
16 8 64 32 16 
16 64 16 16 8 
8 16 16 16 8 
16 16 16 8 8 
8 16 8 4 8 
8 32 16 16 16 
16 64 16 16 16 
aTiters expressed as reciprocal of highest serum dilution having fixation of complement. 
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Table AS. (Continued) 
Weeks of chemical exEosure 
Animal Period 1 .Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group.4 2 4 32 64 128 64 128 64 64 
None 3 4 16 32 32 16 32 8 16 
(chemical 5 16 32 64 64 16 32 16 16 
control) 11 16 32 64 128 128 128 32 32 
12 16 16 32 32 128 256 64 32 
16 16 32 16 128 128 64 32 16 
37 16 32 32 16 16 8 16 16 
39 8 16 16 32 256 64 32 32 
'° Group 5 1 32 64 32 64 32 32 16 8 .... 
None 7 32 0 64 32 64 ·32 8 16 
(infectious 9 64 16 32 64 64 64 16 8 
control) 10 32 32 16 16 16 16 16 16 
14 32 64 64 64 64 64 64 32 
29 8 64 32 !>4 64 64 16 16 
30 32 32 16 32 32 32 32 32 
33 32 16 16 32 128 64 64 64 
Table A6. Serum glutamic oxaloacetic transaminase (SGOT) (Reitman and Frankel units) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 1 8 21 138 110 132 100 116 138 114 
urea 13 150 128 95 116 110 106 114 
0.1 lb/hd/dy 15 80 104 95 80 88 89 106 86 
8 weeks 34 116 94 132 46 78 106 120 60 
35 116 94 132 112 92 94 128 94 
36 138 128 100 80 106 120 102 
38 134 94 100 88 80 106 128 102 
40 94 160 100 94 88 116 138 102 
Groue 2 17 116 94 128 116 100 128 138 102 '° N 
EDDI 18 72 146 122 106 94 119 128 130 
500 mg/hd/dy 19 158 116 88 100 94 138 138 102 
3 weeks; 25 138 116 138 106 128 116 
50 mg/hd/dy 26 106 104 164 116 106 128 122 102 
5 weeks 28 166 122 128 112 116 128 150 114 
31 128 88 138 88 92 94 110 94 
32 88 100 128 106 110 128 130 
Graue 3 4 200 138 116 110 116 150 
EDDI-Urea 6 88 138 118 94. 128 128 130 
50 mg EDDI/hd/dy- 20 80 110 150 100 88 116 138 130 
0.1 lb urea/hd/dy 21 158 110 116 106 92 94 88 148 
8 weeks 22 150 174 150 116 128 128 80 102 
23 138 88 116 106 94 106 120 114 
24 166 100 132 118 72 94 120 86 
27 88 80 128 66 94 116 110 94 
Table A6. (Continued) 
Weeks of chemical exEosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
GrouE 4 2 106 128 106 95 94 106 • 106 114 
None 3 116 94 . 116 116 100 106 106 94 
(chemical 5 66 104 106 106 106 106 106 94 
control) 11 138 116 128 95 84 106 128 86 
12 116 92 106 74 76 80 106 86 
16 106 94 95 106 84 89 110 86 
37 150 122 138 88 94 116 138 114 
39 52 94 95 92 74 88 106 40 
GrouE 5 1 52 50 88 76 58 106 95 78 "' w 
None 7 88 138 106 100 106 116 128 102 
(infectious 9 74 100 128 80 80 89 . 95 86 
control) 10 215 116 84 84 94 106 128 86 
14 106 128 78 95 76 89 106 78 
29 94 94 106 88 88 106 106 86 
30 138 116 138 116 128 128 138 78 
33 88 110 128 40 84 80 106 78 
Table A7. Blood urea nitrogen (BUN) -- mg/100 ml 
Weeks of chemical exposure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 1 8 19 18 14 14 18 8 15 21 
Urea 13 16 22 18 20 21 21 -- 30 
0.1 lb/hd/dy 15 16 15 15 20 17 18 17 21 
8 weeks 34 18 18 10 15 15 14 16 20 
35 22 -- 15 40 21 22 17 28 
36 17 -- 13 16 15 12 15 22 
38 20 16 14 15 15 17 14 24 
40 -- 14 13 15 18 11 16 27 
Group 2 17 15 17 15 11 30 14 20 20 "' -I'-
EDDI 18 19 15 12 17 16 19 17 17 
500 mg/hd/dy 19 28 14 13 20 18 15 15 20 
3 weeks; 25 20 40 18 26 23 25 
50 mg/hd/dy 26 15 14 14 19 14 18 8 17 
5 weeks 28 20 21 16 24 18 18 17 24 
31 16 18 11 27 16 21 21 18 
32 17 18 15 17 14 18 21 20 
Group 3 4 14 14 13 17 17 11 17 
EDDI-Urea 6 15 14 -- 20 14 10 15 20 
50 mg EDDI/hd/dy- 20 13 19 14 24 18 14 15 18 
0.1 lb urea/hd/dy 21 28 19 14 5 19 16 20 17 
8 weeks 22 23 16 11 11 17 18 14 22 
23 21 15 13 8 20 18 14 21 
24 20 17 14 18 19 21 13 25 
27 16 20 8 18 18 18 16 21 
Table A7. (Continued) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 4 2 15 18 16 15 17 6 18 17 
None 3 16 13 17 17 16 11 19 16 
(chemi.cal 5 18 12 18 17 22 16 21 22 
control) 11 17 14 16 11 19 16 20 17 
12 19 10 27 12 19 21 23 18 
16 16 17 14 17 17 18 23 13 
37 17 15 15 15 14 12 16 15 
39 18 15 16 17 17 15 19 20 
Group 5 1 13 16 15 16 19 8 18 19 "' "' None 7 17 9 13 16 16 8 19 22 
(infectious 9 15 13 10 17 17 8 20 21 
control) 10 16 14 15 11 17 10 15 17 
14 13 22 12 14 18 12 19 19 
29 20 17 13 18 14 16 21 22 
30 24 4 15 22 16 15 18 16 
33 18 16 14 15 20 20 21 20 
Table A8. White blood cells -- count/ml 
Weeks-of chemical exeosure 
Animal Period 1 _Period 2 Period 3 
Group number -1 0 l 2 3 4 6 8 
Grou2 1 8 8980 6700 8700 7700 7700 8600 8400 
Urea 13 17300 14200 14300 10700 13700 8800 7000 12800 
0.1 lb/hd/dy 15 6670 5700 7300 4900 7400 5400 4600 9490 
8 weeks 34 8100 7200 5400 5800 7800 12600 7000 8700 
35 7200 6700 5500 7800 5800 8700 7500 
36 12600 8300 6800 9200 11500 13500 12600 11000 
38 8300 5100 6600 12700 8800 19600 -5900 6500 
40 8100 9000 7700 8900 9600 8000 9500 
Grou2 2 17 10750 11300 9400 10000 12700 12600 12000 13600 "' "' 
EDDI 18 11900 10700 8500 7700 5900 8400 11300 11900 
50 mg/hd/dy 19 8260 5600 6000 6000 5700 6700 6600 9100 
3 weeks; 25 13900 11000 9000 10000 11100 15200 11400 
50 mg/hd/dy 26 8600 8200 8200 7400 7300 7700 8200 10850 
5 weeks 28 9150 7300 6200 9500 5200 9200 7800 10900 
31 11000 9200 8000 11000 1700 12400 10400 11600 
32 8200 6000 7300 5800 700 15600 9900 8600 
Grou2 3 4 9500 7700 8100 7700 11300 8500 12500 
EDDI-Urea 6 8700 8300 6900 6700 8400 8300 10200 
50 mg EDDI/hd/dy- 20 8620 7000 6400 7700 6400 10100 6800 7850 
0.1 lb urea/hd/dy 21 7900 9100 10600 9200 7500 7000 9200 11800 
8 weeks 22 9700 8900 8500 11600 8100 7800 14100 
23 7600 7000 9000 7800 9000 9100 6900 8150 
24 14800 10600 10300 9600 10600 11200 12400 11800 
27 8900 6700 8100 7500 8500 12200 8200 11200 
, 
Table A8. (Continued} 
Weeks of chemical exposure 
Animal Period l Period 2 Period 3 
Group number -1 0 l 2 3 4 6 8 
Group 4 2 13800 11300 14200 12600 14300 18200 16200 14900 
None 3 66.90 5800 7900 5300 9000 7000 8400 7830 
(chemical 5 13000 9600 11800 8800 10500 13200 11600 13200 
control} 11 8690 8000 7400 6900 7800 7100 10800 9900 
12 9810 7200 7800 6300 7100 7100 10600 10800 
16 8095 7700 7900 5900 7200 7000 8900 9110 
37 9800 7600 9400 9000 8600 11600 10000 10400 
39 6900 6400 5000 5000 4800 6600 6400 6800 
Group 5 1 10050 7300 11200 14900 8900 10800 6700 12300 "' ...... None 7 8410 8500 9300 6700 10500 9000 10800 11900 
(infectious 9 10500 9000 7700 9500 8800 9300 9400 10300 
control} 10 9220 6500 5600 7200 5500 7000 7300 7090 
14 7680 8500 9000 7600 7300 8300 8500 9490 
29 9750 6800 9900 8800 7600 13600 12500 11200 
30 8670 8500 10700 8500 6800 11600 12300 10300 
33 7300 7700 6900 9500 5300 10000 7900 7300 
Table A9. Lymphocytes -- percent 
Weeks of chemical ex2osure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 1 8 65 75 65 53 69 64 67 
Urea 13 61 66 67 65 54 60 77 
0.1 lb/hd/dy 15 68 58 71 88 73 68 87 
8 weeks 34 59 63 80 65 61 50 70 37 
35 69 75 73 65 81 75 73 
36 71 71 75 64 62 63 57 
38 55 61 63 61 51 47 67 
40 69 67 68 69 76 75 
Group 2 17 66 67 80 66 54 56 71 67 "' 
EDDI 18 60 67 76 79 82 57 54 75 
00 
500 mg/hd/dy 19 69 59 76 64 45 56 78 75 
3 weeks; 25 66 61 78 81 74 70 76 
50 mg/hd/dy 26 77 70 70 79 55 68 74 71 
5 weeks 28 70 68 82 44 72 69 70 81 
31 57 74 86 84 76 74 74 77 
32 87 73 73 93 66 56 87 
Group 3 4 84 70 77 72 61 52 83 
EDDI-Urea 6 76 70 58 63 65 74 81 
50 mg EDDI/hd/dy- 20 71 68 78 67 67 45 59 66 
0.1 lb urea/hd/dy 21 67 75 81 78 76 75 76 77 
8 weeks 22 87 69 79 73 79 75 83 78 
23 81 76 83 69 59 64 84 88 
24 72 66 63 79 64 71 60 70 
27 76 62 79 77 73 56 72 83 
Table A9. (Continued) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 4 2 79 71 86 77 59 75 70 86 
None 3 72 83 84 81 65 80 85 74 
(chemical 5 60 54 61 83 65 64 68 64 
control) 11 80 67 74 69 74 56 73 60 
12 80 37 77 87 80 60 79 84 
16 84 76 79 87 75 72 85 59 
37 75 91 90 87 63 69 82 80 
39 74 62 73 61 55 74 69 
Group 5 1 67· 65 48 45 60 45 78 70 "' "' None 7 64 68 63 63 71 59 62 58 
(infectious 9 71 95 66 60 59 60 73 72 
control) 10 83 69 67 68 56 67 71 71 
14 67 70 76 60 71 73 58 76 
29 85 70 78 87 77 74 70 83 
30 72 69 68 80 73 77 83 66 
33 73 70 82 70 78 64 81 79 
Table AlO. Segmented neutrophils -- percent 
Weeks of chemical exposure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6, 8 
Group 1 8 25 23 30 38 17 25 -- 29 
Urea 13 23 20 21 28 30 33 -- 19 
0.1 lb/hd/dy 15 25 35 21 11 13 21 -- 12 
8 weeks 34 33 35 14 30 21 40 24 37 
35 20 15 18 28 12 22 -- 24 
36 6 12 18 32 12 15 -- 33 
38 27 26 28 37 40 45 -- 26 
40 27 22 29 26 -- 16 -- 22 
Group 2 17 26 13 13 11 13 20 19 12 ..... 0 
EDDI 18 31 9 17 16 9 31 42 20 0 
500 mg/hd/dy 19 21 22 11 17 39 22 17 23 
3 weeks; 25 26 33 21 18 18 26 18 
50 mg/hd/dy 26 10 25 22 15 25 22 20 20 
5 weeks 28 24 24 10 47 17 20 26 12 
31 37 17 10 12 16 21 23 21 
32 0 17 18 6 20 33 -- 13 
Group 3 4 11 26 20 26 21 28 10 
EDDI-Urea 6 18 24 -- 34 21 20 24 18 
50 mg EDDI/hd/dy- 20 17 18 18 27 22 39 36 24 
0.1 lb urea/hd/dy 21 26 16 16 18 13 18 16 12 
8 weeks 22 10 17 13 22 10 18 13 18 
23 12 13 14 28 17 24 12 10 
24 19 24 26 18 12 14 17 21 
27 16 27 21 20 21 32 21 15 
I 
Table AlO. (Continued) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Grou2 4 2 10 17 9 20 23 10 23 11 
None 3 22 5 12 19 20 15 12 22 
(chemical 5 25 41 27 14 51 20 22 30 
control) 11 8 25 22 29 7 23 22 30 
12 10 43 17 11 8 19 19 15 
16 11 19 18 0 8 23 13 35 
37 16 6 8 12 21 12 13 14 
39 19 29 21 33 38 21 23 
Grou2 5 1 18 24 40 39 27 43 18 23 
,.., 
0 
None 7 29 27 31 28 19 20 31 24 .... 
(infectious 9 16 23 20 36 25 19 23 24 
control) 10 11 27 29 31 22 12 23 35 
14 24 20 17 18 13 12 40 22 
29 11 25 19 13 19 20 25 15 
30 15 19 21 17 19 11 18 28 
33 19 25 15 27 18 34 16 20 
Table All. Band neutrophils -- percent 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 1 8 0 0 0 1 10 4 - 0 
Urea 13 0 0 0 0 7 2 - 0 
0.1 lb/hd/dy 15 0 0 1 0 3 6 - 0 
8 weeks 34 0 0 0 0 12 4 1 0 
35 0 0 0 0 2 0 - 0 
36 0 0 1 0 10 5 - 0 
38 0 0 2 0 4 2 - 6 
40 0 0 0 1 -- 3 - 0 
Groue 2 17 0 0 0 1 11 6 0 1 .... a 
EDDI 18 0 0 0 1 1 3 1 0 N 
500 mg/hd/ dy 19 0 2 1 1 3 14 0 0 
3 weeks; 25 0 1 0 0 2 1 3 
50 mg/hd/dy 26 0 0 1 0 5 4 3 0 
5 weeks 28 0 0 0 6 4 2 3 0 
31 0 0 0 0 4 1 0 0 
32 0 0 1 0 0 1 - 0 
Groue 3 4 0 1 0 0 14 13 0 
EDDI-Urea 6 0 0 - 2 13 9 0 0 
50 mg EDDI/hd/dy- 20 0 0 0 3 0 3 0 6 
0.1 lb urea/hd/dy 21 0 0 0 0 0 6 0 0 
8 weeks 22 0 3 0 0 3 6 1 0 
23 0 0 0 0 8 6 0 0 
24 0 1 0 0 3 4 0 0 
27 0 1 0 0 0 3 5 0 
Table All. (Continued) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 4 2 0 1 0 0 12 1 0 0 
None 3 0 0 0 0 12 0 1 0 
(chemical 5 0 0 0 0 6 6 2 0 
control) 11 0 0 0 0 10 0 2 0 
12 0 0 1 0 9 6 0 0 
16 0 0 1 8 7 9 0 0 
37 0 0 0 0 6 4 1 0 
39 2 0 0 2 6 0 0 
Group 5 1 0 2 3 2 8 2 0 6 ..... 
None 7 0 0 1 0 5 15 2 0 0 w 
(infectious 9 0 0 2 6 7 14 1 0 
control) 10 0 0 0 0 17 12 1 0 
14 0 2 1 0 6 11 2 0 
29 0 0 0 0 2 2 4 0 
30 0 0 0 0 2 0 0 0 
33 0 0 0 0 2 1 0 0 
Table Al2. Eosinophils -- percent 
Weeks of chemical ex~osure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Graue 1 8 2 2 3 8 3 4 3 
Urea 13 15 11 10 7 9 5 4 
0.1 lb/hd/dy 15 ,6 4 6 1 9 3 2 
8 weeks 34 6 4 5 5 5 5 3 26 
35 9 8 7 4 4 3 3 
36 3 15 6 3 16 16 9 
38 6 5 7 2 4 6 6 
40 3 7 3 2 0 3 2 
Group 2 17 5 19 7 22 21 8 2 17 ..... 0 
EDDI 18 7 8 5 4 7 8 3 4 
..,. 
500 mg/hd/dy 19 8 15 11 16 12 7 5 1 
3 weeks; 25 6 1 0 1 3 1 3 0 
50 mg/hd/dy 26 2 3 6 5 11 5 3 7 
5 weeks 28 5 6 8 2 6 6 4 3 
31 1 4 3 2 3 4 3 2 
32 7 5 5 0 9 7 0 
Graue 3 4 1 0 2 2 3 7 5 
EDDI-Urea 6 2 4 0 6 2 5 2 0 
50 mg EDDI/hd/dy- 20 11 12 4 3 10 12 5 10 
0.1 lb urea/hd/dy 21 6 5 3 4 10 1 5 6 
8 weeks 22 2 10 1 5 6 1 3 2 
23 7 9 2 2 7 6 1 1 
24 6 6 3 3 17 7 3 7 
27 6 5 0 3 6 6 2 2 
Table Al2. (Continued) 
Weeks of chemical exEosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 4 2 4 7 3 2 4 13 3 1 
None 3 6 5 4 6 2 5 2 4 
(chemical 5 10 3 8 2 8 10 7 5 
control) 11 10 5 3 2 7 9 3 10 
12 5 14 3 1 3 4 1 1 
16 4 4 2 4 8 5 2 3 
37 8 0 1 0 9 4 4 6 
39 4 10 0 3 3 1 3 8 
Group 5 1 12 4 6 3 4 10 3 7 ..... 0 
None 7 6 4 3 2 4 6 5 17 Ln 
(infectious 9 8 2 9 4 9 7 3 2 
control) 10 1 4 4 0 2 4 5 5 
14 3 2 3 2 9 4 0 2 
29 4 3 1 0 2 2 1 2 
30 10 7 1 3 6 9 1 4 
33 6 3 3 1 2 1 1 1 
Table Al3. Monocytes -- percent 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group numbe;, -1 0 1 2 3 4 6 8 
Groue 1 8 6 0 1 0 1 3 - 2 
Urea 13 1 3 1 0 0 0 - 0 
0.1 lb/hd/dy 15 1 3 0 0 2 2 - 0 
8 weeks 34 2 0 1 0 1 1 2 0 
35 2 2 2 0 0 0 - 0 
36 0 2 0 1 0 1 - 0 
38 2 8 0 0 1 0 - 1 
40 0 4 0 2 - 2 - 1 
Groue 2 17 3 1 0 1 1 0 2 0 .... 0 
EDDI 18 2 4 1 0 1 1 0 1 "' 
500 mg/hd/dy 19 2 2 1 2 1 1 0 1 
3 weeks; 25 2 4 1 0 3 2 0 
50 mg/hd/dy 26 1 2 1 0 4 1 0 2 
5 weeks 28 1 2 0 1 1 2 0 3 
31 5 5 1 2 1 0 1 0 
32 0 5 3 1 5 2 - 0 
Groue 3 4 4 3 1 0 1 0 2 
EDDI-Urea 6 4 2 - 0 1 1 0 1 
50 mg EDDI/hd/dy- 20 1 2 0 0 1 1 0 0 
0.1 lb urea/hd/dy 21 1 4 0 0 1 0 3 5 
8 weeks 22 1 0 1 0 2 0 0 2 
23 0 2 0 1 0 0 3 1 
24 3 3 3 0 4 4 0 2 
27 2 5 0 ·o 0 3 0 0 
Table Al3. (Continued) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 4 2 7 4 2 1 2 0 4 2 
None 3 0 7 0 0 1 0 0 0 
(chemical 5 5 2 3 1 0 0 0 1 
control) 11 2 3 1 0 2 2 0 6 
12 5 6 2 1 0 1 1 0 
16 1 1 0 1 2 1 0 3 
37 1 3 1 1 1 1 0 0 
39 1 3 3 1 0 2 6 
Group 5 1 3 5 2 1 1 0 1 0 
,.... 
0 
None 7 1 1 2 0 1 0 0 1 -.J 
(infectious 9 5 0 3 0 0 0 0 2 
control) 10 5 0 0 1 4 5 0 1 
14 6 6 3 0 1 0 0 0 
29 0 2 1 0 0 2 0 6 
30 3 5 0 0 6 1 0 0 
33 2 2 0 2 0 4 2 0 
Table Al4. Packed cell volume -- percent 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 1 8 31 36 36 38 38 33 35 38 
Urea 13 42 40 40 45 39 40 41 36 
0.1 lb/hd/dy 15 36 38 39 34 38 37 40 41 
8 weeks 34 40 39 38 40 39 39 44 40 
35 40 35 42 37 38 37 -- 39 
36 33 32 40 36 33 34 35 35 
38 39 39 38 33 38 32 33 40 
40 36 35 37 35 -- 35 38 40 
,.... 
Groue 2 17 40 37 39 33 38 38 45 39 0 
00 
EDDI 18 36 42 40 36 42 42 45 43 
500 mg/hd/dy 19 40 39 36 35 37 37 38 38 
3 weeks; 25 38 37 39 34 35 35 35 
50 mg/hd/dy 26 36 40 36 40 39 39 43 41 
5 weeks 28 31 35 34 35 35 39 41 38 
31 39 37 40 27 26 31 36 38 
32 35 34 33 37 37 34 38 41 
Groue 3 4 39 42 39 33 37 36 43 
EDDI-Urea 6 37 40 -- 27 38 33 43 38 
50 mg EDDI/hd/dy- 20 33 38 40 36 41 36 39 43 
0.1 lb urea/hd/dy 21 33 35 37 42 37 40 43 35 
8 weeks 22 41 35 35 36 37 39 -- 39 
23 38 39 40 35 41 39 39 36 
24 38 37 39 33 42 37 43 40 
27 34 35 39 38 26 38 41 43 
Table Al4. (Continued) 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Group 4 2 39 39 36 35 36 33 31 39 
None 3 31 35 35 29 34 33 33 39 
(chemical 5 39 40 36 32 35 34 34 40 
control) 11 38 38 39 38 37 34 36 37 
12 44 42 38 40 37 35 41 40 
16 35 35 35 37 37 36 41 39 
37 38 33 35 37 39 33 34 41 
39 38 34 39 36 36 36 30 38 
Group 5 1 38 39 34 35 36 34 34 38 
,.... 
0 
None 7 38 40 39 39 42 40 39 45 >D 
(infectious 9 41 37 38 40 41 38 40 44 
control) 10 47 48 43 39 42 36 43 48 
14 35 35 37 35 38 39 35 38 
29 37 33 38 36 39 39 36 43 
30 34 38 39 38 41 37 40 41 
33 39 24 38 37 38 39 37 44 
Table A15. Fibrinogen -- mg/100 ml 
Weeks of chemical ex2osure 
Animal Period ·1 Period 2 Period 3 
Group number -1 o· 1 2 3 4 6' 8 
Grou2 1 8 100 300 300 300 500 100 -- 100 
Urea 13 500 700 400 1300 700 200 1800 200 
0.1 lb/hd/dy 15 200 400 100 700 300 300 100 100 
8 weeks 34 100 400 200 400 400 300 800 200 
35 400 400 -- 600 600 200 -- 100 
36 200 -- 200 400 700 100 1700 300 
38 100 200 200 800 600 300 1300 200 
40 300 400 400 400 -- 100 900 300 
Grou2 2 17 200 400 300 600 500 300 3300 200 
,... ,... 
EDDI 18 300 400 200 400 500 300 1200 100 0 
500 mg/hd/dy 19 200 500 400 600 400 500 900 100 
3 weeks; 25 300 400 300 300 400 300 500 
50 mg/hd/dy 26 200 500 200 600 600 200 700 200 
5 weeks 28 100 400 300 600 600 200 900 100 
31 400 500 300 800 800 200 400 100 
32 300 500 300 600 600 100 -- 300 
Graue 3 4 300 400 300 900 600 100 1600 
EDDI-Urea 6 100 300 -- 400 500 200 500 100 
50 mg EDDI/hd/dy- 20 300 300 200 600 400 200 300 100 
0.1 lb urea/hd/dy 21 300 300 200 200 500 100 1200 300 
8 weeks 22 200 400 300 300 300 400 -- 200 
23 300 200 200 700 700 300 300 100 
24 200 200 200 200 500 700 1400 100 
27 200 300 200 500 300 300 1000 200 
Table Al5. (Continued) 
Weeks of chemical ex2osure 
Animal Period 1 Period 2 Period 3 
Group number -l 0 1 2 3 4 6. 8 
Group 4 2 300 500 300 100 600 100 500 200 
None 3 300 400 400 100 500 100 200 lOO 
(chemical 5 200 500 400 600 500 200 300 200 
control) ll 500 400 300 500 600 100 400 300 
12 400 200 300 100 40.0 200 100 300 
16 400 400 200 500 500 200 300 200 
37 100 700 200 800 500 lOO 200 300 
39 100 400 300 500 400 300 400 200 
Group 5 l 300 200 300 800 600 lOO 300 300 
,... ,... 
None 7 900 400 200 200 500 200 400 200 
,... 
(infectious 9 300 300 200 500 500 100 400 200 
control) 10 200 300 200 400 500 100 100 100 
14 200 300 200 300 400 600 100 200 
29 500 lOO 300 400 300 100 300 200 
30 300 400 200 600 600 200 200 300 
33 100 300 300 500 700 200 600 300 
Table Al6. Total protein -- g/100 ml 
Weeks of chemical exeosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 1 8 6.7 6.4 6.7 6.9 6.9 6.6 9.5 6.5 
Urea 13 6.3 6.5 6.5 6.6 6.9 7.0 9.5 6.9 
0.1 lb/hd/dy 15 6.7 7.2 7.2 7.0 6.9 6.8 9.5 7.0 
8 weeks 34 8.3 7.1 7.0 7.3 6.9 7.3 10.0 6.0 
35 8.8 7.3 7.4 7.7 7.8 7.5 -- 7.2 
36 7.8 -- 7.3 7.0 7.3 7.4 12.0 7.1 
38 7.1 7.0 7.4 7.9 6.9 7.2 10.0 7.0 
40 7.1 7.1 6.7 6.9 6.3 7.1 10.0 7.5 
Groue 2 17 6.8 7.0 7.2 7.1 7.3 7.0 10.0 'l. 0 ..... ..... 
EDDI 18 7.4 7.5 7.4 7.4 7.7 7.5 8.9 6.6 "' 
500 mg/hd/dy 19 7.3 7.1 6.9 6.8 6.3 6.4 8.2 6.2 
3 weeks; 25 7.0 7.3 7.3 6.5 6.4 6.5 7.3 
50 mg/hd/dy 26 6.9 7.2 6.9 7.4 7 .4 7.2 10.0 7.0 
5 weeks 28 6.6 7.0 6.5 6.6 6.5 6.5 9.2 6.6 
31 6.8 7.3 7.2 6.5 6.6 6.6 7.9 7.3 
32 7.8 7.0 6.5 6.8 6.8 6.5 -- 6.8 
Groue 3 4 6.8 7.5 7.1 7.2 7.1 6.6 8.9 
EDDI-Urea 6 6.4 7.0 -- 6.7 6.8 6.6 9. 8 6.3 
50 mg EDDI/hd/dy- 20 7.2 7.1 7.2 7.2 7.2 6.8 8.4 6.4 
0.1 lb urea/hd/dy 21 6.3 7.1 6.7 6.8 7.2 6.3 11.0 7.4 
8 weeks 22 7.3 7.0 6.9 6.4 6.2 6.8 -- 7.0 
23 7.3 7.2 7.1 7.4 7.0 7.1 7.8 6.7 
24 6.6 6.8 7.1 6.8 7.3 6.8 10.0 7.2 
27 6.7 6.8 7.4 6.7 6.3 6.0 10.0 6.9 
Table Al6. (Continued) 
Weeks of chemical exE:osure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 4 2 7.1 7.5 6.9 6.5 7.0 6.7 7.1 7.1 
None 3 6.9 7.2 6.8 6.5 7.0 6.8 6.9 7.2 
(chemical 5 6.8 7.5 6.8 6.8 6.8 6.8 6.5 7.5 
control) 11 7.2 6.9 6.9 6.8 6.4 6.2 7.1 7.1 
12 1.2 7.0 7.0 6.4 6.5 6 . .7 6.5 7.3 
16 7.1 7.0 7.0 7.0 7.3 6.6 6.5 7.1 
37 7.8 8.1 7.5 7.8 7.3 6.8 6.5 7.1 
39 7.4 7.4 7.0 6.9 6.6 6.8 6.4 6.8 
Groue 5 · 1 6.3 6.5 6.3 7.0 6.4 6.1 7.2 6.4 ..... ..... 
None 7 7.3 7.4 7.0 6.2 7.1 7.1 7.1 7.5 w 
(infectious 9 6.5 6.4 6.4 6.6 6.7 6.4 6.6 6.2 
control) 10 7.8 7.6 7.5 7.7 7.7 6.7 6.8 6.9 
14 7.3 6.6 7.1 6.6 7.0 6.9 6.7 6.7 
29 7.5 7.5 7.0 6.5 6.6 6.5 7.6 6.9 
30 6.9 6.8 7.4 6.9 6.7 6.5 7.0 7.0 
33 8.1 6.6 7.2 7.3 7.5 7.0 6.8 7.6 
Table Al7. Total blood iodine -- ng/100 ml 
Weeks of chemical exEosure 
Animal Period 1 Period 2 Period 3 
Group number -1 0 1 2 3 4 6 8 
Groue 2 17 95 156 860 1259 954 274 281 284 
EDDI 18 191 216 1477 1243 938 282 263 280 
500 mg/hd/dy 19 156 184 1544 1480 1212 276 297 291 
3 weeks 25 126 161 1290 1497 928 235 273 
50 mg/hd/dy 26 117 141 1420 1554 1114 294 273 270 
5 weeks 28 115 159 1389 1393 922 274 280 252 
31 108 107 989 1580 1248 302 264 266 
32 160 171 1424 1404 932 279 288 
Groue 3 4 106 144 260 310 326 261 176 .... .... 
EDDI-Urea 6 110 142 300 268 346 295 310 
..,.. 
50 mg EDDI/hd/dy- 20 72 96 248 296 330 244 244 244 
0.1 lb urea/hd/dy 21 182 181 314 248 334 294 341 237 
8 weeks 22 177 165 202 300 309 246 284 
23 110 156 298 322 321 297 342 324 
24 61 140 292 280 214 149 198 
27 102 104 264 296 298 281 241 282 
Groue 5 1 160 173 186 166 156 169 176 177 
None 7 79 113 119 117 107 113 110 115 
(infectious 9 173 161 167 169 160 156 154 158 
control) 10 128 148 164 164 163 162 166 149 
14 112 154 144 125 132 142 135 116 
29 134 144 144 150 132 146 128 126 
30 100 128 137 124 121 140 134 130 
33 110 111 130 112 134 108 180 
